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ABSTRACT 
This dissertation focuses on the development of analytical methods based on Fourier 
transform ion cyclotron resonance mass spectrometry (FT-ICR MS) and their 
applications for separation and structural characterization of oligosaccharides. Porous 
graphitized carbon liquid chromatography (PGC-LC), gated-trapped ion mobility 
spectrometry (Gated-TIMS), and electronic excitation dissociation tandem mass 
spectrometry (EED MS/MS) are three essential techniques employed here. 
First, the EED method was optimized to generate more informative glycan tandem mass 
spectra for accurate structural analysis. Glycans were reduced and permethylated or 
labeled with a reducing-end fixed charge to increase sensitivity, avoid gas-phase 
structural rearrangement, and facilitate spectral interpretation. EED of glycans produced 
nearly complete series of Z-, Y- and 1,5X-ions, that appear in the spectra as triplets with 
characteristic spacing, thus facilitating accurate determination of the glycan topology. 
Additional radical-driven dissociation pathways were identified, from which different 
types of linkage-diagnostic ions (cross-ring, secondary, or internal fragments) were 
 
 x 
generated. The results demonstrated that linkage analysis can be accomplished by 
utilizing one or a combination of several linkage-diagnostic fragments. 
 
EED MS/MS was then implemented, in conjunction with PGC-LC or Gated-TIMS, for 
on-line separation and characterization of complex mixtures of glycans. These two 
methods were successfully applied for high-throughput and detailed structural analysis of 
N-glycans released from human serum, O-glycans released from bovine submaxillary 
mucin and free oligosaccharides. The performance of these methods was tested and 
improved through analysis of different types of glycans from a variety of biological 
sources. 
 
Finally, in collaboration with bioinformaticians, a spectral interpretation algorithm, 
GlycoDeNovo, has been developed for automated and de novo glycan topology 
reconstruction from their tandem mass spectra. A large number of EED tandem spectra of 
glycan standards generated in house were used as the training dataset to establish 
appropriate IonClassifiers for candidate ranking. GlycoDeNovo is capable of identifying 
correct topologies from MS/MS spectra of glycans in different derivatized forms. Several 
aspects of this collaborative project were covered in this thesis, including glycan 
derivatization, data acquisition and manual spectral interpretation to guide the 




In this thesis research, integrated approaches utilizing PGC-LC–EED-MS/MS and Gated-
TIMS–EED-MS/MS, and the appropriate bioinformatics software, have been established 
for structural analysis of glycan mixtures. They hold great potential for comprehensive, 
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Chapter 1: Introduction to mass spectrometry and oligosaccharides 
 
1.1 Mass spectrometry 
Mass spectrometry (MS) is an analytical method that uses instruments called mass 
spectrometers to measure the mass-to-charge ratios (m/z) of ions, from which their 
masses can be determined, and their elemental compositions may be deduced. A typical 
mass spectrometer consists of three major components: an ion source, a mass analyzer, 
and a detector. In MS analysis, analytes are first converted into gas-phase ions in the 
ionization source. Next, the gas-phase ions are separated based on their m/z values by 
electric and/or magnetic fields in the mass analyzer. After their separation, the detector 
measures and reports the m/z value and signal level recorded for each ion. For structure 
determination, initially formed ions, usually those corresponding to intact molecular or 
molecular adduct species, are selected for detailed study, and these precursor ions are 
isolated and fragmented during one or more stages of tandem MS (MSn) analysis. MS or 
tandem MS analysis results are presented as mass spectra, which are plots of the signal 
intensity of different ions as a function of their m/z values. 
 
The earliest mass spectrometers were developed for studying atoms and small molecules. 
Significant advances in MS technology over the past decades have made it one of the 
most powerful and commonly adopted techniques for analyzing biomolecules. 
Nowadays, MS is widely used for proteomics [1], glycomics [2], metabolomics [3], 
lipidomics [3], genomics [4] and studies of large molecules and non-covalent complexes. 




chromatography (LC) [5], gas chromatography (GC) [6], capillary electrophoresis (CE) 
[7] and ion mobility spectrometry (IMS) [8], to achieve pre- or post-ionization separation 
and identification of compounds in complex mixtures. This chapter provides a brief 




Ionization is the first step in MS analysis. Analytes can be ionized by a wide variety of 
ionization techniques. Historically, MS analysis was limited to small molecules, because 
the early-stage ionization techniques, such as electron impact ionization and chemical 
ionization, require prior thermal vaporization of analytes, and are not compatible with 
analytes, such as large biomolecules, which are non-volatile and thermally unstable. 
Consequently, many researchers worked to find gentler ionization processes, and the 
upper molecular weight limits for MS analysis gradually increased. In mid-1980s, the 
development of two “soft” ionization techniques, matrix-assisted laser 
desorption/ionization (MALDI) and electrospray ionization (ESI), transformed the field 
and enabled MS analysis of non-volatile and high molecular weight species. MALDI and 
ESI are now widely used for biomolecule analysis, as they transfer charge efficiently but 
deposit only low amounts of energy into analytes during the ionization process, thus 
minimizing undesired decomposition of precursor ions. 
 




Electron impact ionization [9], a “hard” ionization method, is one of the first ionization 
methods that was developed for mass spectrometry analysis. The use of high-energy 
electrons in EI usually leads to extensive fragmentation of analyte molecular ions, which 
is useful for determination of structural details but may prevent obtaining the molecular 
weight information of thermally unstable compounds and/or molecular ions that are 
unstable. During the EI process, the analyte molecule is converted to an ion as irradiation 
of high-energy electrons leads to ejection of an electron from the analytes to yield cations 
or capture of an electron to yield anions. Most EI-MS analyses are performed in the 
positive-ion mode. 
  
1.1.1.2 Chemical ionization (CI) and negative chemical ionization (nCI) 
Chemical ionization [10] was invented by Field and coworkers in 1966. Compared with 
EI, CI is a much softer ionization process that deposits a lower amount of energy. During 
the CI process, a reagent gas is introduced into the ionization chamber at a moderate 
pressure, and is preferentially ionized by the high-energy electrons. The ionized reagent 
then transfers its charge (usually via a proton) to the analyte molecule, creating a 
protonated ion. Depending on the energy imparted during the proton transfer, some 
fragmentation of the precursor ion may occur. In CI, the reagent gas serves as a medium 
to pass electron energy to analyte molecules upon collision. The extent of precursor 
fragmentation can be properly controlled by selection of the reagent gas. The ability of CI 




(Alternatively, gases with low ionization potential can be used as the reagents to transfer 
charge to the analyte, in a similar process called charge-transfer ionization.) 
 
nCI [11] is a variant of positive CI. Analytes having strong electron affinity tend to form 
negative ions by capture of low-energy electrons in nCI. Negative ions may also be 
produced by ion/molecule reactions. nCI serves as a good complement to CI for analysis 
of molecules that can be efficiently converted to anions, such as compounds having 
acidic groups or electronegative elements (e.g. halogen-containing compounds). In 
modern MS experiments, nCI is an important technique for generating anion radicals 
utilized as the electron transfer reagent in electron-transfer dissociation (ETD) tandem 
mass spectrometry analysis. 
 
1.1.1.3 Matrix-assisted laser desorption/ionization (MALDI) 
First reported by Hillenkamp and coworkers in 1985 [12], MALDI is a soft ionization 
method that relies on the use of photon-absorbing matrix to facilitate formation of analyte 
ions. To perform MALDI analysis, the analyte is first mixed with a solution containing 
suitable matrix molecules. This mixture is then spotted on a steel target and dried. In the 
ionization source, a pulsed laser beam, matched to the absorption profile of the matrix, 
irradiates the dried mixture, triggering the formation and desorption of both matrix and 





As its name suggests, matrix and laser are essential to the MALDI technique. Matrices 
are usually small molecules that have a strong optical absorption at the UV or IR 
wavelength of the laser used. Commonly used MALDI matrices include α-cyano-4-
hydroxycinnamic acid (CHCA), 2,5-dihydroxybenzoic acid (DHB) and sinapic acid (3,5-
dimethoxy-4-hydroxycinnamic acid, also called sinapinic acid) (SA). Each matrix reagent 
works best for certain types of molecules, therefore, matrix selection needs to be made 
based on the available laser wavelength(s) and the type of analytes anticipated. Common 
lasers employed for MALDI analysis include UV lasers, such as the nitrogen laser (337 
nm) and the Nd:YAG laser (ω3, 355 nm, ω4, 266 nm), and IR lasers, such as the Er:YAG 
laser (2.94 μm). Several models have been proposed to explain the MALDI process, such 
as the gas phase proton transfer model [13], lucky survivor model [13], and the thermal 
model [14]. Generally, when irradiated by a high-power laser, matrices absorb photon(s) 
and accumulate energy, leading to desorption from the crystal and formation of a hot 
plume containing ionized matrix monomers, matrix clusters, analyte molecules, and 
neutrals.  Much of the analyte ionization process may happen in the hot plume via charge 





Figure 1.1 Schematic of the MALDI process and mechanism, adapted from reference [15]. 
 
MALDI is characterized by simple sample preparation, wide mass ionization and 
detection range, minimal in-source decay, fairly high tolerance of salts/contaminants and 
high-throughput analysis. Because of these advantages, MALDI-MS is widely used for 
peptide mapping, protein identification, imaging of biomolecule distributions in tissues, 
and other applications. 
 
1.1.1.4 Electrospray ionization (ESI) 
Since its introduction by Fenn and coworkers in 1985 [16] and their demonstration of its 
utility for protein analysis [17], ESI has become the most prevalently used ionization 
method in modern MS experiments. In fact, the application of ESI to mass spectral 




Natl.Acad. Sci. (Russia), April 1984, 277(2), 379-383), but this information was not then 
widely available in the West. ESI allows analytes to be transferred directly from solution 
to the gas phase under atmospheric pressure. Figure 1.2 demonstrates the process and 
mechanism of ESI. In a typical ESI source, a high voltage is applied to the liquid flowing 
out of a capillary tip, forming a strong electric field between the spray tip and the mass 
spectrometer inlet. The electric field pushes the liquid forward out of the tip, creating a 
tapered aerosol, known as the Taylor cone [18]. When the electrostatic force overcomes 
the surface tension, charged droplets continuously eject from the apex of the aerosol, and 
subsequently break into smaller droplets due to solvent evaporation and increased charge 
repulsion. The process of large droplets breaking into smaller ones due to high surface-
charge density is termed Coulomb fission. Solvent evaporation and Coulomb fission keep 
happening until unsolvated analyte ions are formed. 
 





ESI offers several advantages over previous ionization techniques. First, ESI enables 
online coupling of MS analysis with LC separation, as ESI can transfer in-solution 
analytes into the gas phase in a continuous manner. This opens a new scope of MS 
applications. Second, ESI predominantly results in the formation of multiply-charged 
species of macromolecules, and this factor greatly extends the mass detection range of 
mass spectrometers. Third, ESI is a very soft and sensitive ionization technique. With 
ESI, detection of low-abundance or fragile molecules in biological systems is readily 
possible. 
  
1.1.2 Mass analyzers 
The mass analyzer is a core component of any mass spectrometer. After their formation 
in the ionization source, gas-phase ions are transmitted to the mass analyzer, where they 
are separated on the basis of their m/z values. Mass analysis of ions can be achieved in a 
variety of mass analyzers, based on different principles. The performance of a mass 
analyzer is generally assessed by its mass resolving power, mass accuracy, transmission 
efficiency and dynamic range. 
 
Mass resolving power (R) describes the ability of a mass analyzer to distinguish two 
peaks with slightly different m/z values. As shown in Equation 1.1, R is typically reported 
as the ratio of the m/z value of a peak divided by its full width at half maximum 




reduced sensitivity and/or longer analysis time, an appropriate R should be chosen based 








                                                                                                  Equation 1.1 
 
Mass accuracy describes the difference between the measured m/z value of an ion and its 
theoretical value. In MS, mass accuracy is usually calculated as the ratio of mass 
measurement error to the true value (Equation 1.2), in parts-per-million (ppm). Mass 
accuracy is one of the most important characteristics of MS analysis, as precise mass 
measurement is key to accurate assignments. 
 
Mass accuracy (ppm) = 
|experimental 𝑚/𝑧 − theoretical 𝑚/𝑧|
theoretical 𝑚/𝑧
 × 106                          Equation 1.2 
 
Transmission efficiency refers to the percentage of ions that arrive at the detector from 
the ion source and strongly affects the overall sensitivity of the mass spectrometer. 
Transmission efficiency can be used to estimate the minimal sample amount needed for a 
successful analysis. A good transmission efficiency is essential for detection of low-
abundance species. 
 
Dynamic range in MS indicates the ratio of the highest to the lowest signal intensity that 
can be precisely recorded. A higher dynamic range allows detection of low-abundance 





Mass analyzers commonly used in biomolecule analysis will be reviewed below. 
 
1.1.2.1 Time-of-flight (TOF) 
TOF is a simple, fast and robust mass analyzer. It is ideal for high-throughput MS 
profiling and imaging experiment. TOF determines the m/z value of an ion by measuring 
its travel time from the ion source to the detector. In a TOF mass analyzer, all ions are 
accelerated through an electric field with known electric potential (U). Therefore, their 
kinetic energy (Ek) and velocity (v) can be calculated accordingly [19, 20]. 
 
Ek = zeU = 
1
2




                                                                                                            Equation 1.4 
 
where e refers to the elementary charge, which is the electric charge carried by a single 























Since the ion travel time is proportional to the square root of its m/z for fixed L and U 
(Equation 1.5), the measured flight time of an ion may be used to calculate its m/z value 
(Equation 1.6). The resolving power of a linear TOF analyzer is limited by the length of 
the flight tube, as well as the temporal, spatial and kinetic energy spreads of ions. In 
modern TOF instruments, delayed extraction [21, 22] and a reflection geometry [23] are 
often employed to improve the mass resolving power. With delayed extraction and the 
reflectron, a mass resolving power of well above 10,000 can be easily attained in a TOF 
analyzer. 
 
Figure 1.3 Schematic of a MALDI-TOF instrument, adapted from reference [24]. 
 
A TOF analyzer requires a pulsed ion beam and can be easily coupled to a MALDI 
source. Coupling of a TOF analyzer to continuous ionization sources, such as ESI, may 
be achieved via orthogonal pulsed ion injection, as employed in hybrid quadrupole-TOF 





1.1.2.2 Quadrupole mass analyzer 
As the name indicates, a quadrupole mass analyzer [26] consists of four cylindrical 
electrodes that are assembled parallel to each other (Figure 1.4). A radiofrequency (RF) 
field is applied between two pairs of opposing electrodes with the same potential but 
opposite polarities. An additional direct current (DC) field is applied between the two sets 
of electrodes. The overall potential (Ф0) can be calculated using the RF amplitude (V), 
DC offset voltage (U) and the driven frequency of the quadrupole (ω), as shown in 
Equation 1.7. 
 
Ф0 = + (U – Vcos ωt) or Ф0 = – (U – Vcos ωt)                                                  Equation 1.7                                                 
 
In a quadrupole mass analyzer, ions are selected and separated based on the stability of 
their trajectories in the oscillating electrical field created by the applied RF and DC 
potentials. Stable trajectories of ions of a specific m/z can be determined from the 
Mathieu equation with two parameters au and qu, defined as a function of U and V, 













2                                                                                                          Equation 1.9 
 
Figure 1.4 Schematic of a quadrupole mass analyzer, adapted from reference [28]. 







Mass analysis of a quadrupole mass analyzer is performed by scanning U and V across 
the tip of the stability regions. As long as the scanline passes through the stability 
regions, a steeper scan function, i.e. with a higher U/V ratio, provides a higher mass 
resolving power. A quadrupole mass analyzer is characterized by its low cost, fast 
analysis speed and high sensitivity. However, quadrupole mass analyzers produce limited 
resolving power (1000) and mass accuracy (0.1%), and are most often used as mass 
filters in hybrid MS instruments, or assembled in tandem (QqQ) for targeted or 
quantitative studies. 
 
1.1.2.3 Quadrupole ion trap mass analyzer 
There are two types of quadrupole ion trap analyzers: quadrupole ion traps (QIT) and 
linear quadrupole ion traps (LIT). Their operating principles are similar to that of the 
quadrupole mass analyzer discussed above. A QIT consists of two end-cap electrodes and 
a ring electrode, with only the RF potential applied to the ring electrode to create 
dynamic electric fields for ion trapping. The stability regions of a QIT can also be 
determined from the Mathieu equation. Mass analysis by QIT is typically achieved by 
applying an auxiliary alternate current (AC) potential to the end caps to facilitate resonant 
ion ejection from the ion trap. A QIT is capable of performing multiple rounds of tandem 
MS analysis (MSn) that can provide detailed structural information. In an LIT, ions are 
trapped radially by an RF field and axially by an electrostatic potential. An LIT analyzer 





1.1.2.4 Fourier transform ion cyclotron resonance (FT-ICR) mass analyzer 
Ion cyclotron resonance [29] describes a phenomenon of an ion’s circular motion in the 
magnetic field, in which, its angular frequency is dependent of its m/z value, and is 
independent of its orbit radius (r). The technique of FT-ICR MS was developed by Alan 
Marshall and Melvin Comisarow in 1974 [30, 31] based on the phenomenon of ICR. FT-
ICR MS can provide ultrahigh mass resolving power (>10,000,000) and mass accuracy 
(< 1 ppm). Different from most other mass analyzers, ion trapping in FT-ICR MS is 
assisted by the presence of a magnetic field. 
 
An FT-ICR mass analyzer consists of a magnet field and an ICR cell which is a Penning 
trap. A high-field superconducting magnet is typically utilized since the mass resolving 
power scales linearly with the magnetic field strength (B). Several different designs of the 
ICR cell exist. The ICR cell in the instrument used for this thesis work consists of three 
pairs of electrical plates. Two of these pairs are oriented parallel to the magnetic field, 
responsible for ion excitation and detection, respectively. The third pair is placed 
perpendicular to the magnetic field, and responsible for axial ion trapping. 
 
An ion with a charge of q moving in a homogenous magnetic field (B) at a linear velocity 
of v experiences a Lorentz force (F), and this leads to a circular ion motion around the 




(ω) and cyclotron frequency (f) of the ion are proportional to the magnetic field strength 
(B), and inversely proportional to its m/z value (Equations 1.11 and 1.12). 
 
F = qvB = zevB = m
𝑣2
𝑟











                                                                                                Equation 1.12 
 
During FT-ICR MS analysis, ions are initially trapped radially near the center of the ICR 
cell by the magnetic field, and then excited to a larger orbit successively by an applied 
oscillating electric field at or near their cyclotron frequencies. After excitation, image 
current induced by ions rotating at the detectable orbit is measured by the detecting 
plates, amplified and recorded as a time domain transient. This time domain signal is then 
processed by a Fourier transform algorithm to obtain the frequency spectrum [32], and 
converted to a mass spectrum based on a mass calibration equation. The mass resolving 
power (R) of FT-ICR MS is proportional to the product of the ion cyclotron frequency (f) 
and the recorded transient length (T). Since cyclotron frequency is proportional to the 
magnetic field strength (f ∝ B), the mass resolving power scales linearly with the 













After detection, ions are ejected from the ICR cell through axial ejection by changing the 
trapping plate potentials. 
 
Figure 1.6 Schematic of an ICR cell, adapted from reference [33]. 
 
Despite its significant cost, FT-ICR MS offers superior mass resolving power and mass 
accuracy, making it the ideal instrument for analysis of complex samples with many close 
masses (e.g. petroleomics), or when accurate mass measurement is crucial for structural 
assignment. In addition, the ICR cell is an ion trap, and the presence of the magnetic field 
enables axial electron confinement. This allows the performance of single or multistage 
tandem MS analysis using a variety of fragmentation methods, including collision-
induced dissociation (CID), infrared multiphoton dissociation (IRMPD), ultraviolet 
photodissociation (UVPD) and electron-activated dissociation (ExD). Overall, FT-ICR 
MS is a versatile instrument for detailed structural elucidation of biomolecules. 
 




The orbitrap mass analyzer is another type of Fourier transform mass analyzer that 
employs an electrostatic ion trap [34]. An orbitrap mass analyzer consists of an inner 
axial spindle-shaped electrode and an outer, barrel-shaped electrode that is split into two 
symmetrical segments. A DC potential is applied to the inner electrode, creating an 
electrostatic field with a quadro-logarithmic potential, causing injected ions to oscillate 
radially and axially. As a result, the ion trajectory consists of three motions: rotation 
around the z axis, radial oscillation, and axial oscillation. Each motion has its own 
characteristic frequency. While rotation and radial oscillation frequencies are velocity 
and position dependent, the axial oscillation frequency (ωz) is only dependent on the 





                                                                                                         Equation 1.14 
 
where k is the force constant of the potential, reflecting the field curvature. Ions can be 
optionally excited before detection by applying RF excitation to the outer electrode. Mass 
detection is based on the detected frequency of the alternating image current induced by 
ion’s axial oscillation [35, 36]. 
 
Modern orbitrap mass spectrometers can achieve similar mass resolving power and mass 
accuracy as FT-ICR, and offers faster analysis speed and higher detection sensitivity. 
Therefore, orbitraps have found broad applications in omics studies. Nevertheless, FT-




to its superior mass resolving power and excellent capacity to perform electron-capture 
dissociation (ECD) and electronic excitation dissociation (EED). 
 
1.1.2.6 Comparisons of different mass analyzers 
Details of mass analyzers commonly used in biomolecule analysis have been reviewed 
above. Each of them has their own merits (Table 1.1). In practice, a proper mass analyzer 











TOF 10,000 10 ppm 1-10 fmol 10,000 10,000 Hz 
Quadrupole 1,000 100 ppm 100 fmol 100,000 50 Hz 
Quadrupole 
Ion trap 




100 fmol 10,000 10 Hz 
FT-ICR 10,000,000 < 1 ppm 100 fmol 10,000 1 - 5 Hz 
Orbitrap 1,000,000 < 1 ppm 1 fmol 100,000 12 Hz 
 
Table 1.1 Comparisons of different mass analyzers. 
 
1.1.3 Tandem mass spectrometry and fragmentation methods 
Tandem mass spectrometry, also known as MS/MS or MSn, is a technique that performs 
two or more stages of MS analysis to interrogate the ion structure. This technique may be 
used for protein/peptide, oligonucleotide and oligosaccharide sequencing and detailed 





In a tandem MS experiment, precursor ions of interest are isolated and fragmented, 
generating a series of product ions that may be detected immediately or subjected to 
further stages of MS/MS analysis. Different stages of mass analysis can be conducted 
either in distinct mass analyzers (tandem-in-space) or in the same one successively 
(tandem-in-time). Tandem-in-space MS/MS can be performed in triple quad (QqQ), Q-
TOF and TOF-TOF mass spectrometers. Tandem-in-time MS/MS analyses require mass 
analyzers with the ion-trapping capacity and are usually carried out in ion trap or FT-ICR 
MS instruments; hybrid instruments may offer sequential ion fragmentation/selection 
steps. 
 
Tandem MS analysis involves the fragmentation of the precursor ions. Various 
approaches have been employed to activate and fragment ions for tandem MS. These 
methods usually fall into two categories: slow-heating fragmentation (via vibrational 
excitation) and radical-induced dissociation. More extensive details of the dissociation 
methods employed in this thesis work will be discussed later. Slow-heating methods 
include IRMPD and collision-based fragmentation, such as CID and higher-energy 
collisional dissociation (HCD). Radical-induced dissociation may be triggered by 
absorption of a high-energy photon (UVPD), interaction with metastable atoms or 
radicals (hydrogen attachment/abstraction dissociation, or HAD, and metastable atom 
activated dissociation, or MAD), electron transfer (electron transfer dissociation, or ETD, 




ECD, electronic excitation dissociation, or EED, and electron detachment dissociation, or 
EDD). Each dissociation method has its own merits and limitations. In practice, the 
choice of the fragmentation method depends on the analyte type(s), the analysis goal and 
availability of the appropriate instrument. 
 
1.1.3.1 Nomenclature of glycan fragmentation 
The most widely used glycan fragmentation nomenclature was introduced by Domon and 
Costello in 1988 [37] to explicitly describe glycan fragments produced in MS/MS 
experiments, as illustrated in Figure 1.7. There are two major types of fragment ions, 
resulting from either glycosidic bond cleavages (B-, Y-, C-, Z-ions) or cross-ring 
cleavages (A-, X-ions). Non-reducing-end fragments are termed A-, B- and C-ions, and 
reducing-end fragments are termed X-, Y- and Z-ions. The fragment symbol contains a 
trailing numeral subscript indicating the position of cleavage within the sequence of 
monosaccharides, counting from the non-reducing-end for A-, B- and C-ions, and from 
the reducing-end for X-, Y- and Z-ions. For glycan fragment ions generated from 
branched structures, additional Greek letters (α, β, γ) may be added to the subscript to 
indicate different branches, with α, β and γ in descending order of the branch size (α 
indicates the heaviest branch). For secondary branches, additional subscript, prime (ʹ) or 
double prime (″) may be added, with prime indicating the heavier branch (e.g. αʹ > α″). 
For cross-ring ions, a leading superscript of two numbers is added to indicate the position 
of cleavages within the monosaccharide ring. The six bonds on the pyranose ring are 




fragments are labeled by concatenated fragment symbols that indicate all cleavage sites, 
separating by forward slashes (/), e.g. C3/Z4, or B3/Y3α/Y3β. 
 
Figure 1.7 The Domon-Costello nomenclature of glycan fragmentation, adapted from reference 
[37]. 
 
In tandem MS analysis of glycans, glycosidic fragments are usually used for deducing the 
glycan topology, whereas linkage determinations typically require cross-ring cleavages. 
 
1.1.3.2 Collision-induced dissociation 
Collision-induced dissociation (CID) [38], also known as collisionally activated 
dissociation (CAD), is by far the most commonly used MS/MS technique. CID is 
performed by accelerating precursor ions to collide with neutral gas molecules (typically 
helium, nitrogen or argon), inducing collisional energy transfer to the precursor ion. 















occur. The CID energy is determined by the center-of-mass collision energy, which is 
regulated by the collisional gas used, the analyte size, and the electrical potential applied 
for ion acceleration. 
 
CID is an ergotic process, where intramolecular vibrational energy redistribution (IVR) 
precedes bond dissociation. As a result, the weakest bond(s) within a molecule tend to 
break first. For peptides or proteins, CID usually yields b- and y-type ions via amide 
bond cleavages [39]. For glycans, CID primarily breaks glycosidic bonds to produce B- 
and Y-type ions [40]. This cleavage preference makes CID an appropriate fragmentation 
method for peptide and glycan sequencing. Several different types of CID methods exist, 
depending on the range of the collisional energy and the method used for ion 
acceleration. The term CID often refers to low-energy, resonant excitation (RE)-CID, 
where precursor ions are resonantly excited, typically in a linear or quadrupole ion trap, 
or in an ICR cell (sustained off-resonance irradiation, or SORI-CID). Low-energy CID is 
a “slow-heating” fragmentation method, with each collisional event depositing only a 
small amount of energy (< 1 eV) into the precursor. Multiple collisions are required 
before bond dissociation. A second type of CID is known as beam-type CID, where 
precursor ions are accelerated by up to 100 V of electric potential into a collision cell. 
Beam-type CID may be performed in triple quad, hybrid Q-TOF, or orbitrap MS 
instruments. In the orbitrap platform, beam-type CID is also referred to as higher-energy 
collisional dissociation (HCD) [41]. Beam-type CID can generate dissociation patterns 




secondary fragmentation of product ions. A third type of CID is known as high-energy 
CID, where collisional energy may exceed 1 keV. High-energy CID is typically 
performed in TOF-TOF or magnetic sector instruments and can produce secondary 
fragment ions typically not found in CID with low or moderate collisional energies. For 
example, side-chain cleavages on some amino acid moieties may be abundantly produced 
in high-energy CID of peptide ions, and these fragments are useful for differentiation of 
leucine and isoleucine residues. 
 
Although CID is broadly accessible and universally used as the first approach for peptide 
and glycan sequencing, it sometimes produces inadequate sequence coverage and often 
leads to loss of labile modifications. 
 
1.1.3.3 Electron-activated dissociation  
Electron-activated dissociation (ExD) is a general term that describes a group of MS/MS 
fragmentation methods induced by electron irradiations or electron transfer. These 
approaches include electron capture dissociation (ECD) [42], electron transfer 
dissociation (ETD) [43], negative ETD (NETD) [44], electronic excitation dissociation 
(EED) [45], electron ionization dissociation (EID) [46], and electron detachment 
dissociation (EDD) [47, 48]. This section provides a brief review of ECD, ETD and EED. 
 
ECD [42] was first introduced by Zubarev and McLafferty in 1998 for fragmentation of 




and glycans [49-56]. In ECD, a low-energy electron (< 0.2 eV) is captured by a multiply 
charged precursor, generating an odd-electron radical cation that undergoes further 
cleavage to produce many different fragments. ECD of peptides and proteins produces 
primarily c- and z- type ions by selectively cleaving N-Cα bonds [57]. Similarly, C- and 
Z- type ions are produced in glycans. ECD is usually performed in FT-ICR MS 
instruments, as the presence of the magnetic field is necessary for electron confinement. 
Several designs of ECD cells have been implemented on non-ICR MS instruments, and 
these developments should greatly improve access to the ECD technology [58-60]. 
 
ETD [43, 61] is another widely-used method for producing radical-induced dissociation 
of multiple-charged precursor ions; it was introduced by Hunt and co-workers in 2004. In 
ETD, multiply charged precursor cations are allowed to react with radical anions. The 
ETD reagent ions are typically generated in an nCI source, and the electron transfer from 
the ETD reagent to the precursor produces a charge-reduced radical cation that 
subsequently fragments. Similar to ECD, ETD of peptides and proteins produces 
primarily c- and z-type fragments, with preservation of labile post-translational 
modifications (PTMs), such as phosphorylation and glycosylation, that are often lost 
during CID. A major advantage of ETD is that it can be performed in low-cost 
instruments, such as an ion trap, and is thus more accessible than ECD [61]. For multiply 
charged precursor anions, a radical cation may be used as the electron transfer reagent, in 
a process known as NETD. NETD is very useful for tandem MS analysis of labile acidic 





ECD and ETD are limited to analysis of multiply charged precursors, as both processes 
lead to charge reduction. For analysis of singly charged precursors, EID and EED may be 
used. In EED [45, 55, 64], irradiation with higher-energy (12-18 eV) electrons leads to a 
further ionization step resulting in a charge-increased precursor cation that subsequently 
captures a low-energy electron to induce further fragmentation. For glycans, EED 
proceeds via a two-step process to form a di-radical, open-ring intermediate that will 
further dissociate into fragment ions, as illustrated in Figure 1.8. As the charge state of 
the precursor is not reduced during the electronic excitation process, EED is amenable for 
analysis of singly-charge ions. EED also produces more extensive fragmentation than 
ECD and ETD, generating very complex tandem mass spectra having higher structural 
informational content. 
 









Photodissociation (PD) is induced upon absorption of photon(s) by the precursor ions. 
Infrared multi-photon dissociation (IRMPD) [65] and ultraviolet photodissociation 
(UVPD) are two common PD methods used in peptide and glycan analysis. In IRMPD, 
absorption of a large number of photons is needed to reach the dissociation threshold, 
because each absorbed IR photon adds only a small amount of energy. For example, the 
carbon dioxide (CO2) laser most commonly used for IRMPD operates at λ = 10.6 μm, 
with a photon energy of 0.117 eV. IRMPD is a slow-heating process, and produces CID-
like tandem mass spectra. In UVPD, absorption of a single photon may be sufficient to 
break a chemical bond. An ArF excimer laser (λ = 193 nm) is often used for UVPD of 
peptides. Photons at this wavelength are strongly absorbed by the many amide moieties 
within a protein, producing a large variety of fragments. Glycans do not have a strong 
absorption band in the near UV, and therefore UVPD of glycans can only be achieved by 
analyzing chromophore-derivatized glycans [66] or by using a vacuum ultraviolet (VUV) 
laser, such as the F2 excimer laser that produces photons at λ = 157 nm. 
 
1.2 Biological significance of glycosylation 
Glycomics is the comprehensive and systematic study of all types of free 
oligosaccharides and/or glycoconjugates present in a biological sample, usually a specific 
organism, or a designated component of the organism. Glycosylation is one of the most 




proteins. Though glycans are biosynthesized and remodeled in endoplasmic reticulum 
and Golgi apparatus through non-template-driven process, their mature structures are 
cell-type specific and controlled by activities of the glycosidases and glycosyltransferases 
involved, availability of the nucleotide sugars, and the kinetics of glycan or 
glycoconjugate transport and, in the case of recombinant protein processing, the 
fermentation conditions [67, 68]. 
 
Glycosylation not only plays significant roles in nascent protein folding and structural 
stability, but also impacts a variety of biological processes, such as intracellular 
trafficking, cell-cell communication, immunological response and cancer metastasis [69-
72]. The varied functions of glycans are made possible by their complex and diverse 
structures, and therefore, structural analysis is a vital step towards understanding the 
functions of glycans and glycoconjugates in biological processes and changes in their 





Figure 1.9 Important roles of glycosylation in a variety of biological processes, adapted from 
reference [73]. 
 
1.2.1 N-linked glycosylation 
N-linked glycosylation is the attachment of an oligosaccharide moiety to the side-chain 
amino group of an asparagine (Asn) that is present in a sequon of Asn-X-Ser/Thr (or 
sometimes Cys), where X may be any amino acid except for Pro (Figure 1.10a). In 
eukaryotic cells, all N-linked glycans share a common core structure linked to an Asn 
residue within the sequon defined above: Manα1-3(Manα1-6)Manβ1-4GlcNAcβ1-




complex and hybrid structures (Figure 1.10b). In oligomannose glycans, the core 
structure is extended exclusively by Man residues. In complex N-glycans, GlcNAc 
residues are attached to the core structure, and then can initiate the extension of arms. As 
its name indicates, the hybrid structure is a combination, in which the 6′ arm is extended 
by Man residues only, and the 3′ arm is extended by GlcNAc(s). A bisecting GlcNAc 
residue, usually not further modified, may be attached to position 4 of the inner Man 
residue. 
 
Figure 1.10 N-glycosylation (a) Legend and (b) Classes. 
 
All N-linked glycans are biosynthesized following a three-step pathway [75], starting on 
the cytoplasmic membrane of the endoplasmic reticulum (ER), where a GlcNAc residue 
is attached to the lipid carrier dolichol-phosphate (Dol-P), and then extended to the 
precursor oligosaccharide via the addition of nine Man and three Glc residues in a well-
defined stepwise manner. In the next step, the assembled oligosaccharide chain is 







transferred to a nascent protein to generate the N-linked glycan in the ER lumen as the 
Asn-X-Ser/Thr sequon is translated. In the final step, the N-glycan is processed, initially 
in ER and subsequently in the Golgi apparatus, through the actions of a series of 
glycosidases and glycosyltransferases. The mature glycoform of a N-glycan is protein-, 
cell type- and site-specific, depending on the availability of glycan residues, the 
expression of glycosidases and glycosyltransferases, the status of protein folding during 
the synthesis process, and other potential modifications of the glycan residues (e.g., 
sulfation, phosphorylation, acylation). Similar factors affect glycolipid glycosylation and 
the biosynthesis of free glycans. 
 
N-glycans have important roles in biological systems [76]. For example, appropriate 
effector functions of a monoclonal antibody are maintained by proper N-glycoforms 
attached to its Fc region [77]. Decreased expression of N-glycan galactosylation on IgG 
could stimulate the development of rheumatoid arthritis [78], inflammatory bowel disease 
[79], and systemic lupus erythematosus [80]. Altered N-glycan sialylation has been 
linked to tumor proliferation, invasion, and metastasis [81]. 
 
1.2.2 O-linked glycosylation 
O-linked glycosylation is the attachment of a glycan moiety to the oxygen atom of a Ser 
or Thr (Figure 1.11a). Unlike N-glycosylation, there is no universal sequon for O-
glycosylation. Among all O-glycans, mucin type structures that are initiated by the 





The O-GalNAc glycan series has eight core structures in total (Figure 1.10b), among 
which, cores 1 to 4 are considered the major core structures, since they are more 
commonly detected than cores 5 to 8. Each core can be extended via addition of different 
glycan residues to form linear or branched structures, and, therefore, O-glycan structures 
are more varied. 
 
Figure 1.11 O-glycosylation (a) Legend and (b) Core structures. 
 
O-GalNAc glycans are primarily synthesized in the lumen of Golgi apparatus, and are 
elaborated through the existence of different glycosyltransferases [82]. The biosynthesis 
of O-GalNAc glycans starts with the transfer of GalNAc from UDP-GalNAc to a Ser or 
Thr residue by GalNAc-transferase (GALNT). The further addition of various residues by 
corresponding glycosyltransferases can lead to the formation of different core structures 
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O-glycans have hundreds of complex structures, and, hence, their functions are varied. 
For instance, the presence of terminal Lewis epitopes (the part of an antigen that is 
involved in immune recognition) have profound impacts on immune response and blood 
group determination [82]. O-glycosylation plays important structure-maintainance roles 
in the hinge regions of immunoglobulins. In addition, abnormal changes in O-
glycosylation have been related to some serious diseases, including cancers and 
Alzheimer’s [82]. Other O-linked modifications that involve single glycan residues, most 
importantly O-GlcNAc [83], but also others, e.g., Man [84], Fuc [85], have major 
impacts, and, particularly in micro-organisms [86-88], longer O-linked structures may be 
present. 
 
Glycosylation has been proven to have significant functions in different biological 
processes, including stabilizing proteins, directing transportation of glycoconjugates, and 
mediating cellular signaling [73]. Irregularities in glycosylation are correlated to a variety 
of diseases, such as diabetes [89], autoimmune diseases [72], caners [90], and a growing 
number of defined congenital disorders of glycosylation (CDGs) [91-93]. 
 
1.2.3 Biopharmaceutical significance 
Glycosylation plays pivotal roles in the safety, efficacy and half-life of glycoprotein-
based monoclonal antibody (mAb) therapeutic drugs, and has become an essential aspect 





It is important to understand specific biological functions of different glycoforms, based 
on which, mAb therapeutics can be designed. IgGs, the major mAb therapeutics on the 
market, have a conserved N-glycosylation site at Asn 297 of the Fc region, where 
different N-glycoforms could be added. Distinct N-glycoforms on this site have different 
regulation functions, including control of glycoprotein turnover rate and mediation of the 
binding affinity of IgGs with Fcγ receptors. According to recent studies, IgGs with a G0 
glycoform are more easily bound to a C-type lectin, and, hence, are more likely to be 
removed by dendritic cells and macrophages [95]. The presence of core fucosylation in 
IgGs will reduce glycan-glycan interactions to decrease their binding-affinity to Fcγ 
receptors, and therefore lower the effect of antibody-dependent cell-mediated cytotoxicity 
(ADCC) [96, 97]. Sialylation of the Fc glycans is believed to be involved in modulating 
immune responses and triggering anti-inflammatory effects, via managing the binding 
between IgGs with Fcγ receptors [98]. 
 
Appropriate glycosylation is an important evaluation factor in cell line development for 
final therapeutic protein production. In cell line selection, thousands of cells are screened 
over multiple stages; from these, promising cells are scaled up for more detailed and 
systematic evaluation. Evaluation criteria usually include charge variants, sequence 
variants, aggregation levels and glycosylation patterns [99, 100]. Both enzymatic 





An important consideration in the manufacturing process is minimizing the heterogeneity 
of glycoforms to avoid adverse human immune responses, as adverse immune responses 
initiated by inappropriately controlled glycosylation can lead to serious consequences, 
including cardiovascular failure [101]. For instance, Neu5Gc [102] and terminal α1,3-
linked Gal could be present on recombinant glycoproteins depending on conditions 
during the cell culture process [103]. In such cases, cell culture conditions need to be 
optimized, and relevant analytical techniques need to be included for stringent 
glycosylation monitoring. According to the guidelines of some regulatory agencies, 
identification and thorough characterization of glycosylation is a crucial step in quality 
control of therapeutic protein manufacturing [94]. 
 
Glycosylation is involved in multiple sections of therapeutic protein development and 
manufacturing, ranging from early stage R&D (mAb attribute study and cell line 
selection) to downstream production and quality control. Thereupon, a big challenge in 
therapeutic mAb production is consistent expression of desired glycoforms. Future 
direction in this area will focus on new technology development for customized 
glycoform-engineering and real-time monitoring and controlling of glycosylation 
patterns. 
 
1.2.4 Significance of glycan isomer differentiation 
Glycan biosynthesis is a non-template driven process, consequently, the resultant 




isomers. As described earlier, expression of each isomeric glycan is cell-type specific and 
controlled by many factors during its biosynthesis. Different isomeric structures may 
have different biological functions. 
 
For instance, a terminal sialic acid residue may be linked to a galactose residue via either 
2→3 or 2→6 linkage. In the event of influenza infection, the binding strength of the viral 
hemagglutinin (microbial lectin) to the host receptor varies greatly among different 
species, and the terminal sialic acid linkage configuration on the host receptor is a key 
determinant of the binding specificity [104]. Avian influenza virus bind preferentially to 
2→3-linked sialic acid residues, while human influenza virus trend to bind to 2→6-
linked sialic acid residues [105]. Thus, it is important to develop analytical approaches 
that can separate, differentiate and characterize isomeric glycan structures. 
 
1.3 Glycan structural analysis by mass spectrometry 
Mass spectrometry is a powerful technology for glycan structural analysis. In the general 
procedures for mass spectrometric study of glycans and glycoconjugates, MS1 (MALDI-
MS or LC-MS) is initially employed for determination of glycan composition, and then 
tandem MS, coupled with optimal separation techniques, is further applied for resolving 
isomeric structures and characterizing individual structural details. In this section, sample 
preparation, ionization, separation and MS/MS fragmentation techniques employed for 






1.3.1 Glycan release, purification and derivatization 
Native glycoproteins contain N-linked and/or O-linked glycans attached to amino acid 
residues and, their release is the first step required for their detailed structural analysis. N-
linked glycans can be efficiently released with an enzyme such as N-glycosidase F 
(PNGase F) which catalyzes the cleavage of the glycosidic bond between the innermost 
GlcNAc and asparagine residues (as long as 3-linked Fuc is not present on this GlcNAc 
residue) [106]. A variety of other N-linked endoglycosidases with different specificities 
are also available [107]. Very few (and no general) O-glycosidases are available, so O-
linked glycans are usually chemically released. For reasons discussed below, reductive 
alkaline β-elimination has advantages over otherwise similar procedures [108]. Release is 
not necessary for free oligosaccharides, however, they do need to be isolated from 
complex biological matrices before MS analysis [109]. 
 
All types of glycans can be extracted and purified by similar protocols, as major 
contaminants are similar, such as proteins, lipids and salts. Briefly, proteins, lipids and 
other hydrophobic molecules are removed by using a C18 Sep-Pak cartridge (Waters, 
Milford, MA) under aqueous conditions. After that, the glycans can be purified and 






Mass spectrometric analysis of glycans can benefit from incorporation of glycan- and 
analytical method-appropriate derivatization strategies. For instance, reduction is often 
employed to eliminate anomerism-induced chromatographic peak splitting and 
differentiate non-reducing-end ions from reducing-end ions observed in the mass spectra. 
Permethylation increases volatility and improves detection sensitivity, prevents gas-phase 
structural rearrangement and facilitates spectral interpretation [110]. With linkage-
specific sialic acid amidation, 2→3- or 2→6-linked sialic acid modifications can be 
distinguished [111, 112]. Quantitative information can be acquired by adding a reducing-
end isobaric tag [113, 114]. 
 
1.3.2 Separation techniques 
The analysis of biomolecules extracted from biological systems is usually too 
complicated to be undertaken directly by MS, due to the wide dynamic range of the 
analytes, the possibility of the extracts’ containing MS-unfriendly buffers, and the nearly 
universal existence of structural isomers. In order to obtain an authentic and high-quality 
mass spectrum of each molecule, purification, fractionation, and, most importantly, on-
line separation are necessary steps before MS analysis. Ideally, the separation method 
should be able to resolve each component in a mixture, especially isomeric structures. 
Towards achieving that goal, the community has explored a variety of liquid-phase or 
gas-phase separation techniques and these have been coupled to MS to achieve on-line 





1.3.2.1 Liquid chromatography (LC) 
LC is the most frequently used separation method. The combination of LC with MS (LC-
MS) provides a powerful platform for biomolecule analysis. A wide variety of 
chromatographic modes are available for separation of different types of molecules, 
based on their specific chemo-physical properties. Commonly used LC techniques are 
reviewed here. 
 
Reversed-phase liquid chromatography (RPLC) [115, 116] is one of the most robust and 
reproducible chromatographic techniques. It depends on the principles of hydrophobic 
interactions between the stationary phase and the analyte molecules. RPLC is widely 
applied for the separation of glycopeptides and glycoproteins. However, native glycans 
cannot be directly analyzed by RPLC because their binding properties are dominated by 
their multiple, hydrophilic hydroxyl groups. 
 
Hydrophilic interaction chromatography (HILIC) [117-119] works under a principle 
similar to normal phase liquid chromatography. As its name indicates, HILIC uses a polar 
stationary phase with non-aqueous eluents, and therefore, the operating gradient of 
HILIC is reversed to that of RPLC. HILIC is a common chromatographic method for 
glycan analysis, as native glycans are hydrophilic molecules. HILIC chromatography is 






Porous graphitized carbon (PGC)-LC [123-126] has been demonstrated to be a very 
effective LC method for resolution of isomeric native glycans, derivatized glycans, and 
small glycopeptides. The separation mechanism of PGC is a combination of hydrophobic 
and dipolar interactions occurring between the graphite surface and analytes [127, 128]. 
As shown in Figure 1.12, the excellent isomeric resolving power of PGC benefits from 
the flat surface of graphitized carbon. 
 
Figure 1.12 Proposed mechanism for isomeric structure separation in PGC, adapted from 
references [127, 128]. 
 
Ion-exchange chromatography (IEC) [129] is an important method for separation and 
purification of charged molecules based on their surface net charge. According to the 
isoelectric point (pI) of the molecule of interest, IEC separation is achieved by changing 
the environmental pH or ionic strength to control reversible interactions between charged 
analytes and the oppositely-charged stationary phase. In the project described in the 2nd 
Planar molecules can align closely
with the Hypercarb surface, resulting
in more interaction and retention.
Non-planar molecules cannotalign
closely to the Hypercarb surface,




chapter, a cation-exchange chromatography (Dowex 50WX2 hydrogen form resin) is 
used as a reliable and effective method for recovering reductively aminated glycan (3-AP 
labeled glycans). 
 
Size-exclusion chromatography (SEC) [130], also known as molecular sieve 
chromatography, separates molecules by their size or molecular weight. Molecules of 
different sizes are separated by the effective length that each of them has to travel 
through the SEC column. Smaller analytes are periodically trapped in the pores of the 
stationary phase as they traverse the length of the column, whereas larger analytes simply 
pass by and are eluted first. SEC is generally used for desalting, removing contaminants, 
and fractionation of mixtures whose components differ significantly in molecular weight. 
SEC is utilized in the project discussed in the 2nd chapter to purify 3-aminopyridine (3-
AP) labeled glycans from unreacted 3-AP, which is a very important requirement to 
increase methylation efficiency of the pyridinyl amine, that should take place in the 
following step. 
 
1.3.2.2 Capillary electrophoresis (CE) 
CE [7, 131] is another rapid, sensitive and high-resolution liquid-phase separation 
method. In CE, analytes are dissolved into electrolyte solution and pulled through the 
capillary by an electric field via electroosmotic flow, therefore, all ions migrate in the 
same direction, regardless of their polarities. The separation of ions in CE is based on 




separation in a faster speed: typically, less than 10 min for monoclonal antibodies, and 
less than 3 min for small molecules. Nowadays, an increasing number of CE experiments 
are conducted on microfluidic zipchips, which can remarkably reduce the sample 
injection volume to 50 nL or lower. 
 
1.3.2.3 Gas chromatography (GC) 
GC [132] is a chromatographic technology used to separate and identify components in a 
mixture of volatile molecules. In GC, nitrogen or helium is used as the mobile phase 
(carrier gas) to push analytes forward. The stationary phase consists of a microscopic 
layer of polymer coated on an inert solid support that lines the walls or is packed inside 
the GC column. GC is widely used in qualitative and quantitative studies, such as quality 
control of chemical products and measuring toxic substances in soil, air or water. For 
glycan analysis, GC is usually coupled with EI-MS to enable identification and 
quantitation of monosaccharides. 
 
1.3.2.4 Ion mobility spectrometry (IMS) 
IMS is a family of analytical techniques used to separate and identify ions based on their 
distinct mobility in a carrier gas in the presence of an electric field. Different from other 
approaches discussed above, IMS is combined with MS as a post-ionization separation 
mode. The greatest advantages of IMS are its rapid separation speed and its ability to 
discriminate among analytes based on their molecular shapes. Drift-tube ion mobility 




mobility spectrometry (cyclic IMS), and trapped ion mobility spectrometry (TIMS) will 
be reviewed here. Ions are resolved by their time-distribution in DT-IMS, TWIMS and 
cyclic IMS, whereas, space-distribution in TIMS. 
 
DT-IMS [8, 133-136] is the simplest and most fundamental IMS device, where ions are 
guided by a static electric field to travel through a drift tube and are more or less hindered 
in their transit by the presence of a gas (He or N2). Ion separation in DT-IMS is charge- 
and size-dependent. As shown in Equation 1.14, the mobility of an ion (K) is defined and 
can be calculated from its drift velocity (vd), drift time (td), length of the drift tube (L), 








                                                                                                   Equation 1.14                                           
 





As K value will vary when the temperature or pressure changes, reduced mobility (K0) is 
more widely reported to compare results obtained under different experimental 
conditions. In Equation 1.15, T, T0, P and P0 are temperature, standard temperature 




















                                                                          Equation 1.15 
 
As ions are resolved in a time-dispersed manner in DT-IMS, resolving power (R) is more 





                                                                                                               Equation 1.16 
 
Collisional cross section (CCS) is another characterization parameter to evaluate the 
mobility of an ion in IMS. As defined in Equation 1.17, Ω is the CCS of an ion, z is the 
charge number, N0 is the standard gas number density, kb is the Boltzmann constant, m is 
the mass of carrier gas, and M is the ion mass. Each molecule has its unique CCS value, 




















Despite its simplicity in design, implementation and operation, DT-IMS suffers from its 
low sensitivity and limited mobility resolving power. Most commercial DT-IMS 
instruments provide a mobility resolving power of around 50. 
 
TWIMS [138-140], another IMS technique introduced by Waters Corporation 
(Wythenshawe, UK), is carried out in a low-pressure drift tube, where ions are separated 
inside a RF-only stacked ring ion guide. The transmission and separation of ions in 
TWIMS are achieved by superimposing a RF voltage and a transient voltage pulse. The 
RF voltage is applied to all ring-electrodes with opposite RF phases applied to adjacent 
ring-electrodes to confine ions radically. On the other hand, a propulsive voltage pulse is 
applied on the confining RF of a ring-electrode and then moving the voltage pulse to the 
next ring-electrode, sequentially along the ion-guide, which creates a traveling voltage 
wave (T-wave) to push ions to travel through the ion guide, towards the detector. The 
traveling speed of an ion is dependent on its mobility. An ion of higher mobility may 
keep up with the T-wave and elute earlier, while an ion of lower mobility will fall behind 
the wave and elute in a longer time. In practice, the height and velocity of T-wave need to 
be selected properly according to different types of analytes. In TWIMS, mobility can be 
calibrated by incorporating species with known CCS values [141]. Mobility resolving 





Cyclic IMS is another IMS technique developed by Clemmer and coworkers in 2009 
[143] and refined by Waters Corporation (Wilmslow, UK) in 2019 [144] to improve the 
mobility resolving power via increasing the path-length without a significant increase of 
the instrument size. In cyclic IMS, a closed-loop cyclic ion mobility (cIM) separator 
(placed orthogonally to the main ion motion axis) is adopted to replace the regular ion-
guide device in TWIMS. Therefore, ions with different mobilities could be kept in the 
cIM device and undergo many passes of TW-enabled separation until the desired 
separation has been obtained. A super high mobility resolving power of ~750 has been 
demonstrated for 100 passes of a 98 cm path-length cIM device [144]. 
 
TIMS [145-149] is another high-resolution IMS technique, recently introduced by Bruker 
Corporation, whereby ions are pushed forward by a carrier gas (vg) against a deterring 
electric field gradient. The configuration of TIMS funnel and its operating principles are 





Figure 1.14 Schematic of trapped ion mobility spectrometry, adapted from reference [148]. 
 
As with DT-MS, during TIMS analysis, the drift velocity (vd) of an ion also equals KE, 
where K is the mobility and E is the electric field strength [8, 134]. After being deflected 
into the TIMS funnel, an ion is decelerated by the retarding electric field and eventually 
held stationary in a region where its drift velocity equals the carrier gas velocity 
(Equation 1.18). As ions with different mobilities share the same initial velocity (vg), they 
are spatially separated in the electric field gradient (at t0 in Figure 1.14B). 
 






After spatial separation, the ramp voltage (∆V) is gradually decreased, and this leads to 
the sequential elution of previously trapped ions, from low-mobility to high-mobility 
(shown as t1, t2 and t3 in Figure 1.14B). The TIMS resolving power is calculated in the 
voltage domain, and can be adjusted by altering the carrier gas flow velocity, and the 
ramping speed of ∆V, as slower ramping of ∆V results in higher mobility resolving power. 
The TIMS setup applied in this dissertation is termed as “Gated-TIMS”, which includes a 
pair of split lens downstream of the TIMS funnel, serving as the ion-gate to control the 
open/close of ion transit. 
 
TIMS is most commonly coupled with TOF mass spectrometer (TIMS-TOF MS) [150] as 
TIMS separation occurs in the time scale of milliseconds, and thus needs a fast mass 
analyzer. The Coupling of TIMS to slower mass analyzers is also possible. Gated-TIMS 
[148] is specifically designed to couple with FT-ICR MS or other trapping-type mass 
analyzers. As ion detection of FT-ICR MS is typically performed in a much longer 
timescale (~1s) than TIMS separation, it is not possible to detect all ions eluting from the 
TIMS funnel in a single TIMS event. In Gated-TIMS, the downstream ion gate is used to 
allow only ions within a particular mobility range to pass through and be detected at each 
time. For detection of ions with different mobilities, multiple TIMS cycles are performed 
with the gate-opening at different positions in each cycle. 
 
TIMS has the advantages of high transmission efficiency, superior mobility resolving 





1.3.3 Ionization and fragmentation 
MALDI and ESI are the two major ionization approaches currently adopted for 
oligosaccharide analysis. Most fragmentation methods used in MS/MS analysis of 
peptides/proteins, such as CID, HCD, ECD, EED, ETD, and IRMPD, are also applicable 
for glycans. The choice of ionization and fragmentation methods should be made 
according to the sample composition, experimental purpose and available 
instrumentation. 
 
1.3.4 Other methods for glycan analysis 
Beyond MS, a few other methods are also available and widely applied for glycan 
analysis, although their use is often limited to the assignments or quantification of 
glycans having known structures. While some of these methods work independently, 
others can be coupled with mass spectrometry to provide additional information that 
cannot be obtained from MS alone. 
 
1.3.4.1 Exoglycosidase-based assay 
Exoglycosidase-based assay is usually used together with MALDI-MS or LC-MS for 
terminal residue and linkage characterization. This method involves multi-step enzymatic 
digestions to selectively remove terminal monosaccharides by sequential treatment with 
specific exoglycosidases. From these analyses, the original glycan structure is 




digestion [151]. It is feasible to use this approach for new structure determination, 
however, the procedures are time consuming, and it requires a series of highly pure (and 
often expensive) exoglycosidases, and may leave ambiguities regarding highly branched 
structures whose termini have some common features. 
 
1.3.4.2 Lectin-based microarray 
The use of lectins is a long-established method in glycan analysis, which takes advantage 
of the binding specificities of well-characterized glycan-binding proteins (lectins). This 
method works not only for glycan, but also for glycoprotein and glycopeptide, but may 
have limitations when the specificity is low or certain three-dimensional requirements are 
not met. Applications include ELISA measurements of glycan determinants, blood typing, 
cell sorting and glycoconjugate purification [152]. 
 
1.3.4.3 Cryogenic infrared (IR) spectroscopy 
A major limitation of MS is that it is not capable of determining the three-dimensional 
structure of a monosaccharide to provide unambiguous assignments of stereoisomers. 
This limitation can be overcome by coupling MS with cryogenic IR spectroscopy, which 
can generate high-resolution vibrational spectra that are sensitive to slight differences in 
glycan structures. Cryogenic IR spectroscopy has advantages over regular IR 
spectroscopy because it increases spectral resolution by decreasing the number of 
vibrational states. The application of this method has been demonstrated by its ability to 




of glycans, absorption spectra at the amide (3500-3700 cm‒1) and hydroxyl (3200-3550 
cm‒1) stretching regions are usually carefully examined as different glycan structures are 
often distinguished by absorption spectra in those regions due to their distinct local 
hydrogen bonding [154]. 
 
1.4 Dissertation overview 
This dissertation is centered on the development and application of FT-ICR mass 
spectrometry- based analytical methods for separation and structural characterization of 
oligosaccharides. 
 
Chapter 2 focuses on three parts. First, optimal EED conditions for effective 
fragmentation and structural analysis of glycans were determined. Second, novel glycan 
reducing-end fixed-charge tags were proposed and proven to be advantageous in linkage 
analysis and isomer differentiation. Third, the GlycoDeNovo software being developed 
through an ongoing collaboration was tested and demonstrated to function excellently 
when extended to accommodate glycans that had been subjected to a derivatization 
procedure different from the initially studied permethylation. 
 
Chapter 3 describes the principle of Gated-TIMS and its application for glycan structural 
analysis. Here, Gated-TIMS has been successfully coupled with ExD techniques to 





Chapters 4 and 5 describe the efforts made to couple EED with online LC separation and 
the results of the subsequent analyses. Linkage-specific internal and secondary fragments 
were discovered and these provided definitive 1→2 and 1→3 linkage determinations. 
PGC-LC–EED-MS/MS was established and proven to be a powerful method for 
comprehensive characterization of N-linked and O-linked glycans from biological 
sources. 
 
Chapter 6 concludes the dissertation and provides future perspectives on the continuing 




Chapter 2: De Novo glycan sequencing by electronic excitation dissociation and 
fixed-charge derivatization1 
2.1 Introduction 
The recent boom in -omics is largely catalyzed by the application of tandem mass 
spectrometry (MS/MS) methods to biopolymer sequencing [2, 155]. Compared to the 
rapid growth of proteomics, the rate of progress in glycomics has been notably slower. 
This is, in part, due to the heterogeneity and structural complexity of glycans and thus the 
necessity to determine their branching patterns, linkages, and stereochemical 
configurations to fully define the many closely related structures that frequently occur 
with different distributions at each occupied site. The simultaneous presence of many 
isomeric glycans in biological samples adds a significant layer of challenge to structural 
glycomics, demanding analytical tools that can provide structural details and work well in 
tandem with various glycan separation methods, such as liquid chromatography (LC), 
capillary electrophoresis, and ion mobility spectrometry (IMS), for analysis of complex 
glycan mixtures. 
 
To date, detailed glycan structural characterization is typically achieved by sequential 
tandem MS (MSn) analysis [156, 157], as the conventional collision-induced dissociation 
(CID) method often fails to generate sufficient structural details in a single stage of 
MS/MS analysis. With MSn, a glycan structure can be assigned by comparison with the 
                                                        
1 This chapter is largely based on a published manuscript: Tang, Y.; Pu, Y.; Gao, J.; Hong, P.; Costello, 
C.E.; Lin, C., De novo glycan sequencing by electronic excitation dissociation and fixed-charge 




mass spectra of well-defined standards when its gas-phase disassembly pathways are 
consistently observed. The presence of structural isomers is indicated by the observation 
of anomalous fragment ions; these primary fragments can be isolated and fragmented to 
deduce their structures; when necessary, the cycle can be repeated, so long as sufficient 
signal is detected after each step. Comprehensive characterization of a glycome thus 
requires inspection of many fragmentation pathways for any given precursor ion mass 
and judicious choice of fragment ions at each stage for further fragmentation. The 
inherently lower throughput of the MSn approach and difficulty in its automation have 
hampered its effective implementation with on-line glycan separation. Meanwhile, 
radical-induced fragmentation methods, such as vacuum and extreme ultraviolet 
photodissociation [158-160], charge transfer dissociation [161], free radical-activated 
glycan sequencing (FRAGS) [162, 163], and a variety of electron-activated dissociation 
(ExD) techniques [48, 52, 54, 61, 164], can generate substantially more structural 
information than CID, permitting topology deduction, and sometimes determination of 
linkage and stereochemical configurations, at the MS2 level. Several recent studies 
showed that the integration of radical-induced dissociation with LC or IMS separation 
can be a powerful approach for characterization of glycan mixtures, including those 
containing structural isomers [45, 135, 165-167]. 
 
De novo sequencing of native glycans by tandem mass spectrometry is sometimes 
complicated by gas-phase structural rearrangements [168, 169] or the formation of 




native glycans, an internal fragment has the same mass as a terminal fragment with the 
same saccharide composition, and may be misinterpreted as such, leading to inaccurate 
structural determination. Permethylation is a common strategy that removes such 
ambiguity, since the terminal and internal fragments of permethylated glycans can be 
differentiated based on the number of free hydroxyl groups that represent “scars” left 
behind by glycosidic cleavages that are accompanied by hydrogen transfer to the oxygen 
remaining at the cleavage site. Although permethylation offers several advantages for 
glycan analysis, it is sometimes necessary or desirable to characterize glycans without 
blocking all their free hydroxyl and amino groups, as not all glycans can be 
permethylated and some glycans contain naturally methylated residues. Moreover, the 
presence of those polar groups may facilitate LC separation of isomeric glycans. 
 
A recent report by Gao and Beauchamp presented a clever way to minimize the 
occurrence of internal fragmentation in native glycans by derivatizing the reducing end 
with a methylated (Me)-FRAGS moiety, a radical precursor with a quaternary amine 
fixed charge [163]. Charge sequestration led to suppression of charge-induced 
dissociation during CID of Me-FRAGS-labeled glycans, leaving radical-driven processes 
as the predominant fragmentation pathways. It also resulted in simplified tandem mass 
spectra by promoting detection of reducing-end fragments, while suppressing detection of 
internal fragments that did not contain the fixed charge tag. In CID of glycans with a Me-
FRAGS label, the only internal fragments observed were Z/Z-ions that still retained the 




of two non-reducing-end branches. Finally, methylation at the pyridinyl nitrogen 
prevented protonation at this site and eradicated the possibility for proton-mediated 
saccharide rearrangement that is detrimental to accurate glycan sequencing. 
 
Despite its utility in glycan topology deduction, CID of Me-FRAGS-labeled glycans does 
not produce many cross-ring fragments, except for the linkage-independent 1,5X ions, and 
thus offers little value for linkage position determination. Meanwhile, these glycans with 
a single reducing-end fixed charge cannot be analyzed by either electron capture 
dissociation or electron transfer dissociation, since these methods would generate neutral, 
undetectable products. We have recently shown that singly charged and permethylated 
glycans can be effectively characterized by electronic excitation dissociation (EED) [45, 
55]. This chapter discusses how we first investigated the EED fragmentation behavior of 
unmethylated glycans with a fixed charge modification, and then explored the potential of 
this approach for detailed glycan structural characterization. 
 
2.2 Experimental section 
2.2.1 Materials 
Lacto-N-fucopentaose I, II, and III (LNFP I, II, and III) were acquired from V 
Laboratories, Inc. (Covington, LA). LNFP V, VI, laminarihexaose, maltohexaose, and 
isomaltohexaose were purchased from Carbosynth Limited (Berkshire, UK). HPLC grade 
water, acetonitrile and methanol were obtained from Fisher Scientific (Pittsburgh, PA). 




purchased from Sigma-Aldrich (St. Louis, MO). The proton reagent for acid-catalyzed 
glycan sequencing (PRAGS) was synthesized at Dr. Jinshan Gao’s laboratory at 
Montclair State University, according to the procedure described in a previous report 
[162]. 
 
2.2.2 Me-PRAGS labeling 
One μg of glycan was dissolved in 10 μL of water containing 1% of acetic acid, followed 
by addition of 3 μL of 29.5 mM PRAGS solution in acetonitrile and incubation at 60 °C 
for 5 hr. Solvent was removed with a SpeedVac concentrator (ThermoFisher Scientific) 
after reaction. Methylation of the PRAGS-labeled glycans was achieved by reaction with 
iodomethane in acetonitrile. Me-PRAGS-labeled glycans (Scheme 2.1a) were purified by 
size exclusion chromatography using PD MiniTrap G-10 columns (GE Healthcare, 
Buckinghamshire, UK). 
 





2.2.3 Me-3AP labeling 
Alternatively, a glycan reducing-end fixed charge can be added by using 3-aminopyridine 
(3-AP) via reductive amination, followed by methylation using iodomethane (Scheme 
2.1b). Briefly, 1 μg of glycan was dissolved in 2 μL of water, followed by addition of a 
solution of labeling reagent containing 33 μL of methanol, 3.7 μL of acetic acid, 8.3 mg 
of 3-AP, and 3.2 mg of sodium cyanoborohydride. The mixture was incubated at 37 oC 
overnight. 3-AP labeled-glycan was recovered by Dowex 50WX2 hydrogen-form resin 
(Sigma-Aldrich) and purified by PD MiniTrap G-10 columns (GE Healthcare). For 
methylation, purified 3-AP labeled-glycan was dissolved in a mixture of 50 μL 
acetonitrile and 50 μL of iodomethane, and incubated at 37 oC for 2 hr, followed by 
addition of another 50 μL iodomethane and 2-hr incubation at 37 oC. 
 
2.2.4 Direct infusion mass spectrometry spectra acquisition and analysis 
Derivatized glycans were dissolved in 50/50 (v/v) methanol/water solution to a 
concentration of 5 μM, and directly infused into a 12-T solariX hybrid Qh-Fourier 
transform ion cyclotron resonance mass spectrometer (Qh-FT-ICR MS) (Bruker 
Daltonics, Bremen, Germany) via a pulled glass capillary tip with ∼1 μm orifice 
diameter. EED analyses were carried out with the cathode bias set between 12 and 16 V, 
and an electron irradiation time of 0.5 s. All tandem mass spectra were calibrated with at 
least six fragment ions assigned with high confidence, including Y, Z, and 1,5X ions, 
resulting in a typical mass accuracy of 1 ppm or better for the majority of the assigned 




Bremen, Germany), with the quality factor threshold set at 0.1. MS/MS spectra were 
interpreted manually with the assistance of GlycoWorkbench 2.0 and ChemDraw 15.0. 
 
2.2.5 LC–MS/MS analysis 
For analysis of glycan mixtures, liquid chromatographic separation was performed prior 
to MS/MS analysis. On-line nanoPGC-LC separation was carried out on a 
nanoACQUITY UPLC system (Waters, Milford, MA). Analytes were introduced directly 
into the analytical column from the sample loop, without going through a trapping 
column. A Hypercarb nanoPGC column (3 μm, 75 μm ID × 100 mm) was used as the 
analytical column with the temperature kept at 60 oC. Mobile phase A consisted of 99% 
water, 1% ACN, 0.1% formic acid, and mobile phase B consisted of 80% ACN, 20% 
water, 0.1% formic acid. MS/MS analyses were performed on the same 12-T solariX Qh-
FT-ICR MS used above. On-line EED-MS/MS analysis was performed with the cathode 
bias set at 16 V, and an electron irradiation time of 0.5 s. Auto MS/MS was performed 
with alternating MS scan and MS/MS scans. 
 
2.3 Results and discussion 
Two sets of isomeric oligosaccharide standards were used in this study; their structures 
are shown in Figure 2.1. The first set includes three linear hexasaccharide linkage 
isomers that consist of only glucose (Glc) residues: β1→3-linked laminarihexaose, 
α1→4-linked maltohexaose, and α1→6-linked isomaltohexaose. The second set includes 




structures of LNFP I, II, and V are derived from lacto-N-tetraose 
(Galβ1→3GlcNAcβ1→3Galβ1→4Glc) via the addition of a fucose (Fuc) residue to the 
non-reducing-end galactose (Gal), N-acetylglucosamine (GlcNAc), or Glc residue, 
respectively. LNFP III and VI are related to lacto-N-neotetraose 
(Galβ→4GlcNAcβ1→3Galβ1→4Glc), and they have the same topologies as LNFP II and 
V, respectively, but with different linkage configurations at the GlcNAc residue. All 
glycans were derivatized with the Me-PRAGS or Me-3AP label, which carries a fixed 
charge at the glycan reducing end. 
 
Figure 2.1 Glycan standards used in this study. 
 
2.3.1 EED tandem MS analysis of linear hexasaccharides 
Figure 2.2 shows the EED (16 eV) spectra of Me-PRAGS-labeled hexaose isomers. As 
expected, EED of these glycans with a fixed charge on the reducing end produces 
predominantly reducing-end fragments, in particular, the Z-, Y-, and 1,5X-ion series. The 
only non-reducing-end fragments observed are those of the B-series that carry their own 
charge as oxonium ions. Although many of the observed fragments were generated via 
LNFP I LNFP II LNFP III LNFP V LNFP VI
laminarihexaose maltohexaose isomaltohexaose





glycosidic cleavages or are not linkage-specific, the presence of sets of related fragments 
assists in the interpretation.  For instance, although 1,5X ions provide no linkage 
information, they do have value in de novo glycan sequencing: a pair of Z and Y ions 
may be misinterpreted as a pair of B and C ions of the same saccharide composition, 
whereas a triplet of Z, Y, and 1,5X ions with the mass differences of 18.011 Da (H2O) and 
27.995 Da (CO) between adjacent peaks can be easily differentiated from a triplet of 1,5A, 
B, and C ions whose spacing occurs in reversed order. Complete series of Z, Y, and 1,5X 
triplets are present in EED spectra of all three linear hexaose isomers, and these allow 
correct deduction of the glycan sequences. 
 
Figure 2.2 EED (16 eV) MS/MS spectra of Me-PRAGS-labeled (a) laminarihexaose, (b) 
maltohexaose, and (c) isomaltohexaose. Linkage-specific secondary fragments are labeled in red. 
 
































































































































































A recent study from our laboratory revealed that EED of metal-adducted glycans is 
initiated by ionization and electron recapture, with its fragmentation pattern influenced by 
the energetics of distonic ion intermediates and the stability of product ions [55]. Here, 
EED of fixed-charge-derivatized glycans likely proceeds via a similar mechanism. 
Scheme 2.2 shows the proposed EED fragmentation pathways of Me-PRAGS-labeled 
maltohexaose for the formation of Y•, Z•, and 1,5X ions from various diradicals formed 
upon electron recapture. It had previously been shown that ring opening by the C1−C2 
bond cleavage is favored for sodium-adducted cellobiose due to the resonance 
stabilization of the C1 radical or cation by both O1 and O5. A C1/C2 diradical can 
undergo direct β-elimination to form a 1,5X ion (Scheme 2.2a) or a Z• ion (Scheme 2.2b). 
Because 1,5X ions are closed-shell species derived from the lowest-energy distonic ion, 
they are often the most abundant fragments in the glycan EED spectra. A Z• fragment 
may either lose a β-hydrogen to form an even-electron Z fragment or abstract a hydrogen 
from its complementary C fragment to generate a Z + 2H ion (denoted as Zʺ). Since the 
radical on a Z• fragment is formed after the glycosidic bond cleavage, the extent of 
hydrogen abstraction by a Z• ion is influenced by the lifetime of the C + Z fragment pair. 
Glycosidic cleavage in the middle of the glycan sequence is more likely to produce a 
long-lived complex, as both fragments contain an adequate number of polar groups with 
sufficient conformational flexibility to foster strong noncovalent interactions. The 
strength of interaction is slightly increased for a smaller Z• ion due to the presence of a 
fixed charge on its reducing end. Thus, the relative abundance of Zʺ ions is the highest 




(Figure 2.3). Hydrogen transfer between complementary fragments before product 
separation is a well-known phenomenon in ECD of peptides, leading to the formation of 
z- and c•-type ions [170, 171]. For peptides, it has been determined that the relative 
abundances of c• and z ions is related to the lifetime of post-ECD complex, which can be 
measured in a double resonance (DR)-ECD experiment [172]. In DR-ECD of peptides, 
the charge-reduced species, including c + z ion pairs, are resonantly ejected from the ICR 
cell during ECD, thus depleting the abundance of ions derived from long-lived 
complexes. It is, however, not possible to measure the lifetime of the post-EED C + Z 
pair by DR, because EED does not result in charge reduction, and a C + Z pair has the 
same m/z value as the precursor ion itself. Nonetheless, the hypothesis that formation of 
Z″ ions results from post-EED, intracomplex hydrogen transfer is supported by the 
observation that the relative abundance of Z″ ions drops as the electron energy is 
increased, presumably due to the disruption of noncovalent interactions at higher 
energies. Depletion of hydrogen transfer products was previously reported in AI-ECD of 





Scheme 2.2 Proposed EED mechanism for the formation of 1,5X, Z•, and Y• ions. 
 
Figure 2.3 Zoomed-in regions of the EED MS/MS spectra of Me-PRAGS-labeled (a) 
laminarihexaose, (b) maltohexaose, and (c) isomaltohexaose, illustrating the extent of hydrogen 
transfer products in reducing-end fragments. Each panel shows a comparison of spectra obtained 























































































Formation of Y• ions likely originates from different open-ring diradicals, such as the 
C4/C5 diradical shown in Scheme 2.2c. A Y• fragment can also lose a hydrogen atom to 
form an even-electron Y-2H (denoted as Y⧧) or gain a hydrogen atom to yield a Y ion. 
Unlike in the case of Z• ions, the transfer of a hydrogen atom to a Y• fragment can take 
place either before or after glycosidic bond cleavage, as the radicals initially reside on the 
reducing-end residue in the B/Y fragmentation pathway. The relative abundance of Y 
ions to Y⧧ ions appears to be significantly higher than that of Zʺ to Z ions. A Y ion may 
also be produced by vibrational excitation in closed-shell species, formed via electron 
recapture by a closed-ring radical cation, or through radical recombination in a singlet 
diradical. These alternative pathways do not involve hydrogen transfer, thus the relative 
abundance of Y to Y⧧ ions does not follow the same trend as that of Zʺ to Z ions. There is 
no clear dependence on the size of the fragment, and the relative abundances of Y ions 
increase as the electron energy is increased (Figure 2.3), presumably because the higher 
energy input promotes fragmentation via vibrational excitation. 
 
In addition to the 1,5X, Y, and Z ion series, several linkage dependent cross-ring 
fragments are also observed. The presence of 0,2X ions in all three spectra can be used to 
rule out 1→2 linkages, whereas the presence of 0,4X ion series in the isomaltohexaose 
spectrum can be used to define its 1→6 linkages. In contrast to previously reported EED 
spectra of permethylated glycans with metal charge carriers, the 3,5-cross-ring fragments 




maltohexaose spectrum. For Me-PRAGS-labeled maltohexaose, 3,5A fragments are not 
detected because of charge sequestration at the reducing-end, whereas the complementary 
3,5X ions are diradicals that easily undergo β-elimination to form stable 1,5X ions. 
Meanwhile, several secondary fragment ions generated by EED, for example, Z•-CH2OH 
and Z•-OH, may be useful for linkage analysis. These ions likely derive from Z• radical 
ions via β-elimination of the substituent at an adjacent carbon (Scheme 2.3). For the 
1→4-linked maltohexaose, a Z• ion can lose either its C5 substituent to form a Z•-CH2OH 
ion or its C3 substituent to form a Z•-OH ion (Scheme 2.3a). Loss of CH2OH is 
energetically favored, because the C–C bond dissociation energy is generally lower than 
the C−O bond dissociation energy [175], and the Z•-CH2OH product is further stabilized 
by electron sharing between the newly formed double bond and the O5 atom. 
Consequently, Z•-CH2OH ions are more abundant than Z
•-OH ions in the maltohexaose 
spectrum. For the 1→3-linked laminarihexaose, C/Z cleavage leaves the radical on C3, 
which can only form a Z•-OH ion via direct β-elimination (Scheme 2.3b), but may also 
lose its C5 substituent to form a Z•-CH2OH ion following radical migration to C4. 
Because 1,2-hydrogen migration is associated with a substantial barrier (> 40 kcal/mol) 
[56] whereas direct β-elimination is a barrier-free process, formation of Z•-OH ions is 
kinetically favored. Both Z•-CH2OH and Z
•-OH ions are observed in the laminarihexaose 
spectrum, with the latter series having the higher abundance, in contrast to the trend seen 
in the maltohexaose spectrum. For the 1→6 linked isomaltohexaose, consecutive α-
cleavages from the C6 Z• radical eventually leads to formation of 1,5X ions (Scheme 




1,5X ions, lower-abundance Z ions, and no Z•-CH2OH or Z
•-OH ions. These results show 
that the propensity to form Z•-CH2OH and Z



















Scheme 2.3 Proposed EED mechanisms for formation of secondary fragments from Z• ions at (a) 
1→4, (b) 1→3, and (c) 1→6-linked sites. 
 
2.3.2 EED of LNFP isomers at low electron energies 
Figure 2.4 shows the EED (12 eV) spectra of Me-PRAGS-labeled LNFP isomers, where 
the majority of fragment ions are reducing-end fragments, including complete Y, Z, and 
1,5X-ion series. Again, hydrogen transfer products are observed prominently in moderate-
sized Z-type fragments. The only major non-reducing-end fragments are B-ions or B/Y-
type internal fragments. 
 

































































































































































































































Figure 2.4 EED (12 eV) MS/MS spectra of Me-PRAGS-labeled (a) LNFP I, (b) LNFP II, (c) 
LNFP III, (d) LNFP V, and (e) LNFP VI. Linkage-specific secondary fragments at hexose and 
GlcNAc sites are labeled in red and green, respectively. Internal ions are labeled in blue. 
 
For branched structures, fragments corresponding to cleavages on more than one non-
reducing-end branch may also be produced. These are primarily Z/Z-type fragments at 
the branching point, resulting from the elimination of an entire non-reducing-end branch 
at the β-position of a Z• radical (Scheme 2.4): Z3α/Z3β in LNFP II and III, and Z1α/Z1β in 
LNFP V and VI. Here, loss of multiple residues is also observed at sites distant from one 
another, generating ions such as Z3α/Z1β for LNFP V and VI. Loss of distant residues 
likely occurs as a result of radical migration and not via two consecutive EED processes. 
The presence of Z/Z-type ions can potentially lead to ambiguous interpretation, as they 
also carry the reducing-end tag, and cannot be easily differentiated from reducing-end 
glycosidic fragments based on the accurate mass measurement alone. We recently 
demonstrated that fragment ion assignment can be assisted by examining its context, 
defined as a collection of neighboring peaks within a predetermined mass window. As 
noted above, our results have shown that classifying ions by their contextual features can 
be an effective way to reduce ambiguity in topology reconstruction from EED spectra of 
permethylated glycans [176]. Here, in EED of Me-PRAGS-labeled glycans, a true Z ion 
is almost always accompanied by its corresponding Y and 1,5X ions; these appear as a 
high-abundance triplet with well-characterized mass shifts. In contrast, Z/Z ions are 
generally not observed as part of such a triplet. The only exception is the Z3α/Z3β ion of 




different abundance distribution than that of a typical Z, Y, 1,5X-triplet, allowing easy 
differentiation by a properly trained IonClassifier [176]. IonClassifier is an effective 
ranking of candidate topologies, and is automatically learned from tandem MS spectra of 
known glycans to distinguish one type of ion from all other ion types. 
 
Scheme 2.4 Proposed mechanisms for formation of internal fragments: (a) Z3α/Z3β of LNFP III 
via direct β-elimination, (b) Z3α/Z1β of LNFP VI via radical migration, and (c) Z3α/Z1β of LNFP VI 
via consecutive EED processes. 
 
Accurate glycan topology analysis requires not only the presence of informative 
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‡ (LNFP VI), m/z 630.250
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also elimination of undesirable gas-phase structural rearrangements, most commonly 
observed as fucose migration during CID of native or reductively aminated glycans, or 
for fragments from permethylated glycans, particularly for those derived from protonated 
precursors [169, 177, 178]. Fucose migration can result in the formation of Z ions that 
have either lost or gained a fucose residue. The presence of the former, however, is not 
indicative of the occurrence of fucose migration, as it can also result from loss of multiple 
terminal residues as described above. For example, the ion at m/z 648.262, observed in 
the EED spectra of Me-PRAGS-labeled LNFP II and III, can be assigned as a Y3α/Z3β (or 
Y3β/Z3α) ion. Unlike the high-abundance Z3 ion of the same composition from LNFP I, 
Y/Z ions are not accompanied by their corresponding Y/Y and Y/1,5X ions, and can be 
easily ruled out as a simple Z ion during topology analysis. In these mass spectra, there 
are no Z ions with an unexpected addition of a fucose residue that would implicate fucose 
migration. For example, the Z (Hex2Fuc) ion (m/z 591.240) only exists in the EED 
spectra of LNFP V and VI (Z2α), but not in the EED spectra of LNFP I, II, and III. The 
fragment ion at m/z 590.255 in the LNFP II and III spectra is not related to Z (Hex2Fuc), 
and is tentatively assigned as Z3β/Z3α-CH2CO. Similarly, the Z (HexNAcHex2Fuc) ion 
(m/z 794.319) is observed in the EED spectra of LNFP II, III, V, and VI (Z3α), but not in 
the LNFP I spectrum. 
 
At 12 eV, EED of LNFP isomers generates only a few low-abundance 0,2X ions. In 
contrast, linkage-informative secondary fragments, Z•-CH2OH and Z
•-OH ions, are 




trend as that observed in the EED spectra of linear hexaose isomers. At 1→4-linked sites, 
Z•-CH2OH ions are more abundantly formed than Z
•-OH ions, for example, Z1
•-CH2OH 
for LNFP I, II, and III, Z1α
•-CH2OH for LNFP V and VI, Z3β
•-CH2OH for LNFP II, and 
Z3α
•-CH2OH for LNFP III and VI. On the other hand, secondary fragmentation at 1→3-
linked sites produces Z•-OH ions in higher abundance than Z•-CH2OH ions, for example, 
Z2
•-OH for LNFP I, II, and III, Z2α
•-OH for LNFP V and VI, Z3
•-OH for LNFP I, and 
Z3α
•-OH for LNFP V. Because the mass difference between a Z•-OH ion and a Z ion is 
the same as that between a Fuc and a Gal residue, in branched structures containing both 
terminal Fuc and Gal residues, it is not possible to determine the abundance of a Z•-OH 
ion following the loss of a Fuc residue. Specifically, Z3β
•-OH is isomeric to Z3α in LNFP 
II and III and Z1β
•-OH is isomeric to Z3α in LNFP V and VI. In cases like this, it is 
important to recognize the potential for ambiguity in peak assignment, and look for other 
evidence that may assist in linkage analysis. For example, in LNFP III, the presence of a 
high-abundance Z3α
•-CH2OH ion and the absence of a Z3α
•-OH ion would place Gal at the 
C4 position of the GlcNAc residue, thus leaving only the C3 position as the possible 
linkage site for Fuc, since the C2 position of a GlcNAc residue is already occupied by an 
acetylamino group, and C6 substitution would have eliminated the Z•-CH2OH pathway 
altogether which contradicts with the observation of an abundant Z3α
•-CH2OH ion. 
 
In contrast to linear hexaose isomers consisting solely of hexose residues, LNFP glycans 
also contain GlcNAc residues that can give rise to additional fragmentation pathways. 




C/Z cleavage, for example, Z3
•-CH2CO in LNFP I and Z3α
•-CH2CO in LNFP II and V, 
whereas CH3CO loss from a Z
• ion is observed at all 1→4 linked GlcNAc sites, for 
example, Z3β
•-CH3CO in LNFP II and Z3α
•-CH3CO in LNFP III and VI. Thus, although 
differing in mass by only that of a single hydrogen atom, these secondary fragmentation 
pathways can provide additional information that facilitates linkage analysis at GlcNAc 
sites. Scheme 2.5 shows the proposed mechanisms for these GlcNAc-specific 
fragmentation pathways. 
 
Scheme 2.5 Proposed mechanisms for formation of linkage-specific fragments at a GlcNAc 














2.3.3 EED of LNFP isomers at higher electron energies 
Figure 2.5 shows the EED spectra of Me-PRAGS-labeled LNFP isomers acquired with 
cathode bias set at 16 V. Irradiation with higher-energy electrons leads to more efficient 
EED, as evidenced by the increased abundance and improved signal-to-noise ratio of 
most fragment ions. It also opens up new fragmentation channels. Some of the fragments 
that are observed only in higher-energy EED spectra are highlighted. In particular, EED 
at 16 eV leads to formation of some doubly-charged fragment ions. Generation of 
fragment ions in charge states one higher than that of the precursor ion was previously 
reported in electron ionization dissociation (EID) of peptide cations [179]. Since 
ionization itself does not cause dissociation of the resultant radical, it was suggested that 
EID of peptides proceeds via tandem ionization followed by electron capture, forming an 
electronically excited, charge-increased radical cation that subsequently dissociates. In a 
similar way, the EID process may have contributed to the formation of doubly charged 
fragments here. 
 
Importantly, the extent of formation of cross-ring fragments is significantly boosted at 
higher electron energies. For example, all four of the potential 0,2Xn ions are observed in 
the 16 eV EED spectrum of LNFP I, whereas only one 0,2X4 is observed in its 12 eV EED 
spectrum. Linkage-informative secondary fragments are also more abundantly formed, 
especially for those derived from smaller Z• ions. For example, Z1
•-CH2OH (m/z 
253.118) is observed just above the noise level in the 12-eV EED spectra of LNFP I, II, 





•-OH fragments (m/z 429.187) of LNFP I, II, and III, and Z2α
•-OH fragments (m/z 
575.245) of LNFP V and VI, are on average four times more abundant in the 16-eV EED 
spectra, as compared to the 12-eV spectra. Thus, linkage analysis may be more easily 
achieved with higher-energy EED spectral data. 
 
At 16 eV, EED also produces more internal fragments. The presence of internal 
fragments with the reducing-end label could potentially complicate topology analysis. 
However, triplets of internal fragments are rarely observed, and such fragments typically 
have an order of magnitude lower abundance when compared to simple Z, Y, and 1,5X 
ions, even in higher-energy EED spectra. Further, these internal fragments, except for the 
Z/Z fragments that result from cleavages at the branching sites, are either absent or have 
very low abundances in the lower-energy EED spectra. Thus, it may be advantageous to 
perform topology analysis based on lower-energy EED spectra, and use higher-energy 





Figure 2.5 EED (16 eV) MS/MS spectra of Me-PRAGS-labeled (a) LNFP I, (b) LNFP II, (c) 
LNFP III, (d) LNFP V, and (e) LNFP VI. Fragments formed by EED at 16 eV, but not at 12 eV, 
are highlighted. 
 
2.3.4 De novo topology elucidation 
The EED spectra of glycans are significantly more complex than their CID spectra, and 
more challenging to interpret manually, especially when the structures are unknown. 
Together with our collaborators, our group has recently developed a de novo glycan 
sequencing software, named GlycoDeNovo, which can efficiently deduce and accurately 
rank the glycan topologies from their tandem mass spectra [180]. The contribution from 























































































































































































































the author of this thesis to the overall work is the large set of EED spectra generated for 
native and derivatized glycan standards, and the careful manual interpretation of the 
spectra that guides algorithm development and evaluation. GlycoDeNovo identifies 
potential B- and C-type glycosidic fragments sequentially, by attempting to interpret a 
heavier fragment as a combination of a monosaccharide (root) and one or more 
previously identified, lighter, non-reducing-end glycosidic fragments (branches), 
eventually leading to the interpretation of the precursor ion. The candidate topologies can 
then be ranked either by the number of supporting peaks (SPN) or, more accurately, by 
the cumulative IonClassifier scores of supporting peaks. IonClassifier is an effective 
ranking of candidate topologies, and is automatically learned from tandem MS spectra of 
known glycans to distinguish one type of ion from all other ion types. IonClassifier is a 
measure of confidence in peak assignment, and obtained via machine learning from 
tandem MS data of glycan standards. 
 
GlycoDeNovo was initially written for analysis of tandem mass spectra of permethylated 
glycans. Here, the algorithm has been modified to accommodate the mass differences 
between native, reducing-end modified, and fully permethylated glycans. In addition, 
because EED of Me-PRAGS-labeled glycans produces predominantly reducing-end 
fragments whereas GlycoDeNovo builds candidate topologies from the non-reducing end, 
complementary peaks are artificially added to the peak list before analysis. IonClassifier 
was retrained with the EED tandem mass spectra of Me-PRAGS-labeled glycans, as they 




training involves boosting [181] the decision tree classifier [182] using the experimental 
tandem mass spectra of known glycan standards. Each decision tree utilizes one or 
several contextual features of a peak to decide probabilistically if the peak is a B/C ion. 
The features include both the mass shifts of the neighboring peaks with respect to the 
peak of interest, and the abundances of those neighboring peaks. The final score is the 
weighted sum of the output from all decision trees. The weight of each tree is 
automatically learned by the boosting procedure from the training data. The number of 
trees is capped at 100 in the present implementation. 
 
Table 2.1 shows the topology analysis result by GlycoDeNovo on the 16-eV EED spectra 
of Me-PRAGS-labeled glycans. The challenge of de novo glycan sequencing is evidenced 
by the number of peaks interpretable as non-reducing-end glycosidic fragments that is 
significantly higher than could be generated by the actual structures. For example, the 
pentasaccharide LNFP VI can produce a maximum of four B ions and four C ions, but 40 
peaks are interpretable as B or C ions. Fortunately, most of these peaks do not lead to 
eventual interpretation of the precursor ion, and coincidental matches can be further 
discriminated against by IonClassifier. As glycans can have branched structures, even a 
small number of interpretable peaks can lead to prediction of many candidate topologies. 
For the three linear hexasaccharides consisting of only hexose residues, 11 candidate 
topologies (structures not shown here) are deduced when the search is limited to 
bifurcated structures. GlycoDeNovo correctly ranks the linear topology as the top 




with one to five hexose residues. In contrast, only a subset of these fragments may be 
used to support other candidate topologies. 












































10 11 1 (0) 1 (0) 264.93 241.41 
 
Table 2.1 Topology analysis by GlycoDeNovo on EED (16 eV) spectra of Me-PRAGS-labeled 
glycans. 
 
For branched structures, e.g., LNFP II, III, V, and VI, however, ranking by SPN alone is 
often insufficient for determining the correct topology among several co-ranked 
candidate structures. This is perhaps not surprising, especially for analyses such as the 
example given here, that are performed on spectral data generated by higher-energy EED, 
which promotes formation of secondary and internal fragments. In particular, Z/Z-, Y/Z-, 
and Y/Y-type ions, as well as secondary ions that still contain the reducing end, can be 
easily misinterpreted as Y- or Z-type ions, even with the reducing-end tagging. 
Nevertheless, these ions lack the features displayed in actual sequence ions, including, 




much lower IonClassifier scores. When ranked by IonClassifier, the true topology is 
always identified as the top candidate by itself in each case. 
 
Accurate de novo glycan sequencing is no simple task, especially without permethylation. 
By combining the power of reducing-end fixed charge tagging, EED, and a well-designed 
glycan sequencing algorithm, this study represents a significant step toward that goal. 
 
2.3.5 LC–EED-MS/MS analysis of isomeric glycan mixtures 
Because of the highly ubiquitous presence of glycan isomers, it is desirable to conduct 
separation before MS analysis to avoid interferences from isomeric components. In this 
study, on-line separation of glycans with a reducing-end fixed charge was carried out 
with porous graphitized carbon liquid chromatography (PGC-LC) at elevated 
temperatures, as PGC-LC provides superb resolution for glycan isomers and applicability 
towards analytes with a wide range of polarities [128]. More details of using the PGC 
chromatography for glycan analysis will be thoroughly discussed in a later chapter 
(Chapter 5). Here, some preliminary results are shown in this section. 
 
In the initial experiment, chromatographic peak splitting was observed in PGC-LC 
separation of Me-PRAGS-labeled glycans (Figure 2.6a and b), which could result in 
reduced sensitivity and complicate analysis by distributing the ion signal and also lead to 
interference in MS/MS spectra from co-eluting isomers (Figure 2.6c). The observed peak 




structures. Anomerism-induced chromatographic peak splitting may be eliminated by 
employing a new derivatization strategy, where the glycan reducing end was modified via 
reductive amination using 3-AP, followed by methylation of the pyridinyl amine to 
introduce a fixed charge (Scheme 2.1b). 
 
Figure 2.6 NanoPGC-LC‒MS analysis of Me-PRAGS-labeled (a) LNFP I, (b) LNFP II, and (c) 
mixture of LNFP I and II. 
 
The EED fragmentation behaviors of Me-3AP-labeled glycans were evaluated, and found 
to be very similar to those of Me-PRAGS-labeled glycans. Complete series of Z, Y, and 
1,5X triplets with characteristic spacing were generated. Identical types of linkage-
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glycan derivatives exhibit EED fragmentation efficiency similar to the Me-PRAGS-
labeled derivatives, but are much more cleanly separated by liquid chromatography. As 
shown in Figure 2.7, each Me-3AP-labeled isomer only appears as a single peak in PGC-
LC. The mixture of LNFP I, LNFP II and LNFP III labeled with Me-3AP can be baseline 
resolved by PGC-LC. 
 
Figure 2.7 NanoPGC-LC‒MS analysis of a mixture of Me-3AP-labeled LNFP I, II, and III. 
 
2.4 Conclusions 
In this study, the EED fragmentation behavior of fixed-charge-labeled glycans was 
examined by employing two sets of isomeric glycans representing both linear and 
branched structures with a variety of linkage configurations. EED tandem mass spectra of 
these glycans are characterized by complete, prominent 1,5X, Y, and Z ion series, as well 
as many linkage-informative cross-ring and secondary fragments. Although the EED 
efficiency is improved by raising the electron energy, higher-energy electron irradiation 
does lead to formation of more secondary and internal fragment ions. It appears that 
combining spectral information in EED spectra acquired at two electron voltages may be 
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determination can be achieved by the in-house developed algorithm “GlycoDeNovo”. 
The potential of PGC-LC–EED-MS/MS for characterizations of mixtures of isomeric 
glycans with a reducing-end fixed charge was also investigated. In addition, the fixed-
charge labeling protocol was modified to include reduction of the reducing end, in order 
to overcome the issue of chromatographic peak splitting. The progress achieved in this 





Chapter 3: Separation and structural analyses of isomeric glycans by gated-trapped 
ion mobility spectrometry–electron activated dissociation tandem mass 
spectrometry2 
3.1 Introduction 
Ion mobility spectrometry [133-136, 183-187] has recently emerged as a powerful 
alternative for separation of isomeric structures, including glycan isomers. IMS 
complements liquid-phase separation techniques in that it is a post-ionization, gas-phase 
separation method, wherein analyte ions are sorted on the basis of their masses, charges, 
and shapes, i.e., the properties which affect the magnitude of their cross-sections. Isomers 
may differ in collisional cross section (CCS) and, therefore, ion mobilities, depending on 
their gas-phase conformations; furthermore, a single structure may exhibit more than one 
conformation. IMS analysis is generally faster than LC and the separation and IM 
measurement can be easily incorporated into the MS analysis. Moreover, the CCS 
value(s) of an analyte ion is an additional property which can be used for its 
identification. 
 
Significant progress in glycan structural characterization has been made through the 
development of electron-activated dissociation tandem MS methods [48, 64, 188, 189]. In 
particular, EED, ETD and negative electron transfer dissociation (NETD) [44, 62, 63] are 
                                                        
2 This chapter is largely based on a published manuscript: Wei, J.; Wu, J.; Tang, Y.; Ridgeway, M.E.; Park, 
M.A.; Costello, C.E.; Zaia, J.; Lin, C., Characterization and quantification of highly sulfated 
glycosaminoglycan isomers by gated-trapped ion mobility spectrometry negative electron transfer 




capable of generating extensive glycosidic and cross-ring cleavages, thus allowing 
confident sequence and linkage determination. 
 
EED, ETD and NETD MS/MS analyses are performed on a time scale longer than the 
conventional drift-time IMS separation. It is possible to couple IMS separation with 
slower analysis methods when the IMS device is used as a mobility filter [134, 190]. 
Trapped ion mobility spectrometry (TIMS) [146-149, 165] offers high mobility 
resolution and ion transmission efficiency and has shown great promise in isomer 
separations. Operation principles of TIMS are described elsewhere in this thesis (section 
“1.3.2.4 Ion mobility spectrometry”). Successful coupling of TIMS to FT-ICR MS has 
been achieved under the selected accumulation (SA)-TIMS mode and applied to 
characterization of isomeric glycan mixtures [165]. However, SA-TIMS requires 
extended ion storage time in the TIMS analyzer, leading to significant ion heating and is 
therefore not suitable for analysis of labile compounds or compounds whose conformers 
may interconvert during the storage time. As discussed below, this limitation may be 
overcome by employing Gated-TIMS wherein ions of a given mobility are selected by an 
electrical gate and accumulated in a low-pressure collision cell [148, 191]. Here, the 
initial results obtained for coupling Gated-TIMS to EED and NETD MS/MS are 
presented. The utility of Gated-TIMS–EED-MS/MS and Gated-TIMS–NETD-MS/MS is 
demonstrated for characterization of isomeric oligosaccharides. 
 





All Me-PRAGS labeled glycans were prepared following the protocol described in the 
previous chapter [162]. Glycosaminoglycan (GAG) standards, GlcA-GlcNAc6S-IdoA-
GlcNAc6S-(CH2)5-NH2 (Compound 1), GlcA-GlcNAc-IdoA2S-GlcNAc6S-(CH2)5-NH2 
(Compound 2), GlcA-GlcNS6S-GlcA-GlcNS3S6S-GlcA-GlcNS6S-(CH2)5-NH2 
(Compound 3), GlcA-GlcNS6S-GlcA-GlcNS3S6S-IdoA-GlcNS6S-(CH2)5-NH2 
(Compound 4), and GlcA-GlcNS6S-GlcA-GlcNS6S-IdoA2S-GlcNS6S-(CH2)5-NH2 
(Compound 5) were synthesized by the Boons group at the University of Georgia. All 
GAG standards were alkylated at the reducing end via an α-linkage that will facilitate 
fragment assignment and eliminate anomerism-induced conformational heterogeneity. 
All other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
 
3.2.2 Gated-TIMS–MS and Gated-TIMS–ExD-MS/MS analysis 
All experiments were carried out on a Bruker 12-T solariX FT-ICR mass spectrometer 
equipped with a prototype TIMS device (Bruker Daltonics, Billerica, MA) [148]. Glycans 
were dissolved in 40:60 water/methanol with 0.1% formic acid to a concentration of ~5 
pmol/μL. Around 5 μL of sample was loaded into a pulled glass capillary tip with a 1 μm 
orifice diameter and then introduced into the mass spectrometer via static 
nanoelectrospray. The schematic of the TIMS device and the principles of the Gated-
TIMS operation have been described in detail [148]. Briefly, ions entering the TIMS 
funnel were trapped radially by an RF potential (190 Vpp) and axially by an electric field 




Following a 9-ms trapping event, the strength of the axial electric field was gradually 
decreased by ramping the TIMS analyzer entrance potential from 250 down to –50 V, to 
allow elution of ions in the order of ascending mobilities. Each time a downstream ion 
gate was pulsed open, it allowed only ions of a selected mobility to pass through and be 
accumulated in the collision cell. For MS/MS analysis, ions of a given mobility were 
selected on the basis of m/z by a quadrupole filter before entering the collision cell. The 
drift gas (nitrogen) pressure was regulated between 2.5 and 2.7 mbar, depending on the 
mobility resolution needed. ESI-L Low Concentration Tuning Mix (Agilent 
Technologies, Santa Clara, CA, USA) was used to optimize mobility resolving power and 
sensitivity. Gated-TIMS–EED-MS/MS analysis was performed with the cathode bias set 
at 16 V, and an electron irradiation time of 0.5 s. For Gated-TIMS–NETD-MS/MS 
experiments, fluoranthene cation radicals were generated by a chemical ionization source 
with argon as the buffer gas. A reagent accumulation time of 0.2 to 0.5 s and a reaction 
time of 50 to 100 ms were typically used. 
 
3.2.3 Spectra interpretation 
All spectra were processed by DataAnalysis 4.4 (Bruker, Bremen, Germany) and 
interpreted manually assisted by GlycoWorkbench 2.0 [192] and ChemDraw 15.0 
(PerkinElmer, Waltham, MA). Fragments were annotated according to the Domon-
Costello nomenclature [37]. 
 




3.3.1 Reduced ion heating during Gated-TIMS analysis 
TIMS is commercially available only on time-of-flight MS instruments (Bruker); 
separation occurs on the millisecond time scale, and thus is more easily coupled to a fast 
mass analyzer. TIMS coupling to slower analysis methods, such as ExD-FT-ICR MS/MS, 
was first accomplished by modifying the axial EFG profile to include an electric field 
plateau for selective accumulation of ions with the desired mobility inside the TIMS 
tunnel, as implemented in SA-TIMS [165]. However, prolonged ion accumulation during 
SA-TIMS (hundreds of milliseconds) can result in the radial ion cloud expansion and 
multipole storage assisted dissociation (MSAD) [193-195]. In contrast, Gated-TIMS 
involves a short ion accumulation time in the TIMS tunnel (around 10 ms), and multiple 
collision cell fills are used to increase the abundance of ions of the desired mobility and 
to match the time scale of FT-ICR MS analysis. The collision cell has a much higher 
space charge capacity and lower gas pressure (∼10–3 mbar), and consequently, ion 
storage here minimizes MSAD. Suppression of lower-abundance ions of interest in the 
collision cell is not an issue following mobility selection and m/z filtering. 
 
The advantage of Gated-TIMS over SA-TIMS for analysis of labile compounds is 
illustrated in Figures 3.1, showing the influence of the TIMS accumulation time on the 
extent of sulfo (SO3) loss from a highly sulfated HS hexasaccharide. Although extensive 
sulfo losses were observed when the TIMS accumulation time exceeded 100 ms (Figure 
3.1d and e), sulfo loss was negligible with a 10 ms TIMS accumulation time, even after 




ions did not coelute with the precursor, it was concluded that the sulfo losses had taken 
place primarily inside the TIMS tunnel. Another advantage of Gated-TIMS is that the 
reduced ion storage time minimizes conformational changes. Heating-induced 
conformational change at longer trap times was previously reported for TIMS-TOF MS 
analysis of ubiquitin ions [196]. Thus, Gated-TIMS is well suited for analysis of glycans 





Figure 3.1 (a) ESI mass spectrum of a highly sulfated HS hexasaccharide acquired in the 
transmission mode (TIMS off). (b-f) Averaged mass spectra of the same compound acquired with 
different TIMS accumulation time and number of collision cell fills. 
 
3.3.2 Improving mobility resolving power and sensitivity 







































(b) 10 ms, 60 fills
(c) 50 ms, 60 fills
(d) 100 ms, 60 fills
(e) 200 ms, 60 fills





Mobility resolving power and sensitivity are two important performance metrics of 
Gated-TIMS analysis. In the early stage of development, much effort was spent to discern 
the mechanisms behind the separation and improve these two characteristics. According 
to the principle of Gated-TIMS [145], only ions held momentarily on the electric plateau 
(red rectangle in Figure 3.2) of the TIMS ramp are detected in each operation cycle. 
Therefore, a high-resolution separation is usually carried out with a slow voltage ramping 
speed (small value of voltage offset) and a shallow or flat electric plateau. 
 








As its name indicates, Gated-TIMS features a downstream ion gate, whose timing (pulse 
delay) and width (pulse duration) have significant influences on the ion transmission 
efficiency, and thence detection sensitivity. The accurate position of the ion gate is 
dependent on the velocity of the carrier gas, and can be experimentally determined. A 
proper ion-gate width is ideally sufficient to allow transmission of all the ions with the 
desired mobility, but narrow enough to minimize transmission of ions with other 
mobilities. In practice, an ion gate duration of 10 TOF pulses, or 1000 μsec, is commonly 
adopted which provides a balance between resolving power and sensitivity. 
 
As shown in Figure 3.3, with the optimization of voltage ramping speed and the ion-gate 
setting, a mobility resolving power of around 120 may be achieved for the tuning mix 
standards. 
 
Figure 3.3 Separation of tuning mix standards by optimized Gated-TIMS. 
 
The performance of the system for glycan analysis, when operated under these optimal 
Gated-TIMS conditions, was also investigated. The extracted ion mobiligrams (EIMs) of 














       o    o                   o        S               o    o          





Me-PRAGS-labeled LNFP I and II are displayed in Figure 3.4, as plots (a) and (b), 
respectively. In contrast to results obtained from PGC-LC analysis (Figure 2.6), each 
analyte appears a single peak in the Gated-TIMS analysis. This result may have been 
obtained because the resolving power of Gated-TIMS is not high enough to separate the 
potentially different conformations, or only one gas-phase conformation exists for each 
Me-PRAGS-labeled glycan. The signal abundance (~4 × 107) obtained in this experiment 
was not adequate for definitive structural determination by ExD analysis. It was thus 
apparent that further improvements of resolving power and sensitivity were needed to 
make Gated-TIMS a practical tool for isomeric glycan analysis. 
 
Figure 3.4 Gated-TIMS–MS analysis of Me-PRAGS labeled LNFP I and II. 
 
3.3.3 Gated-TIMS–EED-MS/MS analysis of Me-PRAGS labeled oligosaccharides 
Unlike SA-TIMS, the design of Gated-TIMS allows ions of the desired mobility occupy 
only a small section of the mobility analyzer during the operation. External accumulation 
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of ions of interest via multiple collision cell fills may be employed to increase the ion 
abundance for effective ExD analysis. The impact of multiple fill cycles on the analysis 
speed can be reduced with accumulation during detection (ADD), where ion 
accumulation is performed in parallel with MS analysis of the previous ion packet in the 
ICR cell. In the analyses whose results are shown here, 600 to 900 fill cycles were used 
prior to EED. 
 
Figure 3.5 shows the EIM of Me-PRAGS-labeled LNnT and LNT, and EED spectra 
acquired at different peak positions. Among five peaks present in Figure 3.5a, peaks 1 
and 2 can be assigned as different gas-phase conformations of the same glycoform 
(presumably LNT), on the basis of their identical EED spectra (Figure 3.5c). Similarly, 
peaks 3, 4 and 5 generate the same EED spectrum (Figure 3.5b), and thus may be 
assigned as different gas-phase conformations of another glycoform (presumably LNnT). 
According to the EED fragmentation mechanism proposed in Scheme 2.3, LNnT and 
LNT can be distinguished by different abundance ratios of Z3
•-CH2OH to Z3
•-OH ions 





Figure 3.5 Gated-TIMS–EED-MS/MS analysis of Me-PRAGS labeled LNnT and LNT. (a) 
EIM of the precursor ion, [M]+, m/z 828.32. (b) EED spectrum acquired at peak 3. (c) EED 
spectrum acquired at peak 1. Asterisks mark the electronic noise. 
 
3.3.4 Separation of GAG isomers by Gated-TIMS 
Apart from facile sulfo losses, challenges in MS analysis of GAGs may also arise due to 
the presence of multiple precursor ions corresponding to each glycoform that occur 
because of the range of charge states and cation-adducted species; this heterogeneity 
reduces S/N for analyte peaks and complicates the MS analysis. For IM-MS analysis with 
direct infusion, the ionization conditions, including the pH and composition of the ESI 
solution, can be adjusted to achieve at least some control over the charge state 
































































































































reduced cation adduction. The analyte charge states also affect the ion mobility 
separation and the NETD spectral quality. Though the NETD efficiency increases with 
the precursor ion charge state, GAG isomers in higher charge states tend to produce more 
extended - and thus similar - gas-phase structures that are difficult to resolve by IMS. At 
the start of the analysis, rapid survey scans at relatively low mobility resolution may be 
performed to define the best conditions for separation of isomeric structures. The 
experimental parameters can then be tuned for higher-resolution scans within targeted 
mobility ranges. 
 
Gated-TIMS separation results obtained for two sets of GAG isomers are shown here. 
The first set contains two dp4 isomers with moderate degree of sulfation (Compound 1 
and 2), and the second set contains three dp6 isomers with high degree of sulfation 
(Compound 3, 4 and 5). As shown in Figure 3.6, isomers in both sets can be baseline-
resolved by Gated-TIMS in the 3– charge state. In each EIM plot, the x-axis displays the 
elution voltage of analytes. The CCS value of each compound (Figure 3.6, bottom panel) 
could be calculated on the basis of its elution voltage using a calibration curve established 
with a series of compounds of known mobilities [146]. The CCS of an analyte is a fixed 
value when measured under the same conditions and can be stored in a database for 
future reference. Here, the high mobility resolving power offered by Gated-TIMS was 





Figure 3.6 Gated-TIMS separation of two sets of dp4 and dp6 isomers. (a) EIMs ([M − 3H]3−) of 
Compound 1 (blue trace), Compound 2 (red trace), and their mixture (black trace). (b) EIMs ([M 
− 3H]3−) of Compound 3 (blue trace), Compound 4 (green trace), Compound 5 (red trace), and 
their mixture (black trace). Measured CCS values from each experiment are listed below the 
plots. 
 
3.3.5 Gated-TIMS‒NETD-MS/MS analysis of dp4 isomers 
In experiments performed in parallel to the Gated-TIMS–EED-MS/MS analyses, external 
accumulation of ions of interest in the collision cell was performed to increase the ion 
abundance for Gated-TIMS-NETD-MS/MS analysis. For structural characterization, each 
mobility- and m/z-selected isomer was subjected to NETD in the collision cell. 
 
Figure 3.7 shows the NETD tandem mass spectra of the two dp4 isomers isolated by 
Gated-TIMS. Peak assignment was facilitated by the high-mass accuracy FT-ICR MS 
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measurement and the presence of the reducing-end aminopentyl group. NETD generated 
many glycosidic and cross-ring fragments without sulfo losses, including several 
fragment ions unique to each isomer. In both spectra, the presence of Y1 and Z1 ions 
containing one sulfo group may be used to assign one sulfation site to the reducing-end 
GlcNAc residue. For isomer 1, the second sulfation site may be localized to the internal 
GlcNAc residue, on the basis of the mass difference between its Y3
2− (or Z3
2−) fragment 
ion (with 2S) and Y2 (or Z2) fragment ion (with 1S) (Figure 3.7a); for isomer 2, the 
second sulfation site can be assigned to the internal IdoA residue on the basis of the mass 
diference between its C2 (with no S) and C3−2H (with 1S) ions (Figure 3.7b). For each 
isomer, the location of the sulfation on the reducing-end GlcNAc residue can be defined 
as the 6-O position, on the basis of the observation of the 3,5A4 ion containing two sulfo 
groups. Likewise, the second sulfo group in isomer 1 can be assigned to the 6-O position 
of the internal GlcNAc residue, on the basis of the observed 3,5A2 ion with one sulfo 
group. Definitive evidence for the exact location of the sulfo group on the interior HexA 
residue of isomer 2 is not present in the spectrum shown here, but this sulfo group is 
presumed to be located at the 2-O position on the basis of known biosynthetic pathways. 






Figure 3.7 Gated-TIMS‒NETD-MS/MS analysis of a mixture of Compounds 1 and 2 in the 3− 
charge state. (a) Online NETD spectrum of peak 1 in Figure 3.6a. (b) Online NETD spectrum of 
peak 2 in Figure 3.6a. Asterisks mark the electronic noise. 
 
3.3.6 Gated-TIMS‒NETD-MS/MS analysis of highly sulfated dp6 isomers 
Characterization of the dp6 mixture presented a bigger challenge. First, it is difficult to 
achieve complete deprotonation on these highly sulfated compounds, with the result that 
proton-mediated facile sulfo losses can occur during ionization, mobility analysis, and 
ion transfer. Second, the presence of many sulfate and carboxyl groups resulted in a 
broad charge state distribution and the formation of many sodiated and ammonium-
adducted forms. Such heterogeneity complicates subsequent MS/MS analyses. Third, 

























































































































































































































higher NETD efficiency, these dp6 isomers could not be fully resolved in 4− and 5− 
charge states. To overcome these challenges, the instrument parameters and the ESI 
solvent composition had to be optimized to minimize cation adduction and sulfo losses, 
and then, the 3− charge state was chosen for NETD analysis, since it was determined that 
all three isomers could be mobility resolved in this charge state. 
 
The NETD spectra of the mobility-selected dp6 isomers are shown in Figure 3.8. In the 
NETD spectra of peaks 1 and 2 (Figure 3.8a and b), the Y2 ions contain only two sulfate 
groups. This, along with the presence of Y3 and Z3 ions with five sulfate groups, suggests 
that the second GlcN residue is fully sulfated. In contrast, in the NETD spectrum of peak 
3 (Figure 3.8c), the mass difference between its Y1 (with 2 S) and Y2 (with 3 S) ions 
indicates that the HexA residue near the reducing end is singly sulfated, agreeing with the 
structure provided for Compound 5. This assignment is confirmed by the presence of 
high-abundance Z2-COOH, 
1,5X2 ions with three sulfate groups, and the B5
2− fragment 
with five sulfate groups. Thus, it is relatively easy to distinguish Compound 5, from its 
sulfation positional isomers, Compounds 3 and 4, on the basis of their NETD spectra. 
 
Distinction between the other two sample components, presumably the stereoisomeric 
Compounds 3 and 4, is more difficult. For both isomers, it is possible to locate all 
sulfation sites on the basis of the complete series of glycosidic fragments and 3,5A and 
0,2A ions originating via cross-ring fragmentation at the first and third GlcNAc residues. 




isomers, may sometimes be differentiated by MS/MS on the basis of unique 
fragmentation patterns associated with each stereochemical configuration [197-200]. 
Amster and co-workers showed that the C5 uronic acid stereochemistry near the reducing 
end in HS tetrasaccharides may be determined by EDD MS/MS, on the basis of the 
differential ratio (DR) in the abundances of specific cleavages in this region, DR = 
log(1/3(Σ(B3,Y1,C2,Z2))/(Σ(Y2,
1,5X2))), where a positive DR value is associated with 
GlcA and a negative value, with IdoA [197]. Even though this strategy cannot be directly 
applied to determine the epimeric configuration in the compounds studied here, because 
of the difference in the chain length, charge state, and the fragmentation method 
employed, the DR value may still be used for differentiation. Here, the 1,5X2 ions are not 
observed, and the Y2 ions have similar abundances, whereas fragments resulting from 
glycosidic cleavages at the reducing end side of the epimeric center, namely, Y1, Z1, B5
2−, 
and C5
2− ions (labeled in green in Figure 3.8b), are about 2 to 5 times more abundant in 
the NETD spectrum of peak 2 than in that of peak 1. As peaks 2 and 1 correspond to 
GlcA5-containing Compound 3 and IdoA5-containing Compound 4, respectively, on the 
basis of the elution time observed for individual dp6 standards, it appears that glycosidic 
cleavages on the reducing end side of GlcA are more prevalent than those next to IdoA. 
Moreover, the abundance of the cross-ring fragment, 0,2X4
2−, is eight times greater in 
Figure 3.8b than in Figure 3.8a, suggesting that the epimeric configuration can influence 
fragmentation distant from the stereochemical center, potentially providing additional 
information for epimer differentiation. Thus, it is possible to assign these two 




3.6b) or their NETD fragmentation patterns. Here, Gated-TIMS‒NETD-MS/MS analysis 
provided both CCS values and the fragmentation data to enable confident identification. 
 
Figure 3.8 Gated-TIMS‒NETD-MS/MS analysis of a mixture of Compounds 3, 4, and 5 in the 3− 
charge state. (a) Online NETD spectrum of peak 1 in Figure 3.6b. (b) Online NETD spectrum of 
peak 2 in Figure 3.6b. (c) Online NETD spectrum of peak 3 in Figure 3.6b. 
 
3.4 Conclusions 
This study explored the analytical potential of combining Gated-TIMS separation with 
ExD-MS/MS for characterization of isomeric glycan mixtures. The investigation took 
advantage of the fact that Gated-TIMS can function in both the positive and negative 
































































































































































































































(a) Peak 1 (Cpd. 4)
(b) Peak 2 (Cpd. 3)


























































































































































modes. Multiple gas-phase conformations of Me-PRAGS labeled glycan isomers were 
resolved by Gated-TIMS in positive mode and the detailed structure of each 
conformation was determined by EED spectra acquired online.  
 
Synthetic GAG isomers of dp4 and dp6, including sulfation positional isomers and 
IdoA/GlcA stereoisomers, were baseline resolved by Gated-TIMS in negative mode, and 
their CCS values were measured and stored for future reference. Online Gated-TIMS‒
NETD-MS/MS generated extensive fragmentation with a high degree of sulfo retention 
for their detailed structural characterization, along with many diagnostic fragments for 
isomer differentiation. 
 
Gated-TIMS‒ExD-MS/MS has been demonstrated to be a powerful tool, with advantages 
of superb mobility resolving power, high transmission efficiency and preservation of 
labile modifications. 
 
* Experiments that involved the coupling of Gated-TIMS with ExD-MS/MS (3.3.3 to 





Chapter 4: RPLC–EED-MS/MS analyses of reduced and permethylated glycans3 
4.1 Introduction 
Glycosylation is one of the most ubiquitous and diverse posttranslational modifications, 
occurring in approximately half of all eukaryotic proteins [201]. At the cell surface, 
glycans exert their functions by modulating the extent and specificity of the interactions 
between glycoconjugates and their binding partners [202]. It has become increasingly 
evident that compositional glycan profiling is insufficient and detailed glycan structural 
determination is required to correlate their functional features with defined structural 
parameters. A prime example is the recent discovery that the sialyl Lewis x (sLex) 
tetrasaccharide sequence, rather than its linkage isomer, sialyl Lewis a (sLea), represents 
the major carbohydrate ligand for human sperm-egg binding [203]. Differential 
expression of sLea and sLex was also observed during tumor progression and metastasis 
in cancers [204]. 
 
Glycomics is the comprehensive and systematic study of all types of glycans, whether 
free or in conjugated forms, that are present in a biological system [2, 205]. Although 
glycosylation often starts with common core structures, these undergo extensive, 
unscripted enzymatic modifications during passage through the endoplasmic reticulum 
and the Golgi apparatus, resulting in tremendous diversity in mature glycan structures, 
with variations in their composition, branching patterns, linkage positions, stereochemical 
                                                        
3 This chapter is largely based on a published manuscript: Tang, Y.; Wei, J.; Costello, C.E.; Lin, C., 
Characterization of Isomeric Glycans by Reversed Phase Liquid Chromatography-Electronic Excitation 





configurations, and chemical substituents [206-208]. Such structural complexity and 
heterogeneity of glycans are the hallmarks of their template-free biosynthesis, and 
necessitate the development of analytical methods that combine detailed structural 
determination with on-line or off-line glycan separation for comprehensive glycome 
characterization. Preferably, the separation method should be able to resolve the isomeric 
structures that are often present in biological samples. 
 
Capillary electrophoresis (CE) with laser-induced fluorescence (LIF) is routinely used for 
glycan analysis due to its high sensitivity, analysis speed, unmatched separation 
efficiency, and ability to quantify [7, 131, 209-211]. Since fluorescence-based detection 
methods do not provide definitive glycan identification, structural elucidation by CE-LIF 
is often carried out by investigating the relative migration shifts following various 
exoglycosidase treatments. Such an approach can suffer from low throughput, poor 
reproducibility in electrophoretic migration times, and limitations in number of glycan 
standards in CE databases. In contrast, mass spectrometry analysis, and in particular, 
tandem mass spectrometry (MS/MS) can be used to deduce the glycan structures without 
the need for glycan standards. Although the coupling of CE to MS has shown tremendous 
promise for characterization of isomeric glycans, compromises must be made in the CE-
MS interface and on the buffer additives, and this can lead to reduced CE separation 





As described in the previous chapter, Ion Mobility Spectrometry (IMS) is another 
powerful tool well suited for separation of isomeric glycans, as isomers vary in their gas-
phase conformations, and hence often have different collisional cross sections and 
mobilities. IM-MS/MS separation and characterization of mixtures of isomeric glycan 
has been demonstrated on several MS platforms [165, 183-187, 212, 213]. However, IMS 
is not completely orthogonal to MS, and generally does not have a high peak capacity. 
Moreover, when employed as a post-ionization method, IMS does not address the 
challenge of ionization suppression, and this limits the dynamic range of glycans that can 
be simultaneously characterized by IM-MS. IM-MS analysis can also be complicated by 
the presence of multiple gas-phase conformers for a single isomer. 
 
LC–MS has long been the method of choice for analysis of complex mixtures, owing to 
the complementary nature of the LC and MS separations. A wide variety of 
chromatographic modes target different chemo-physical properties of analytes, allowing 
their separation based on their size, charge, polarity, and/or hydrophobicity. Resolution of 
isomeric glycans has been demonstrated by strong anion exchange (SAX) 
chromatography [214], high-pH anion exchange chromatography (HPAEC) [215-217], 
hydrophilic interaction chromatography (HILIC) [119, 218, 219], reversed phase LC 
(RPLC) [220-222], and porous graphitic carbon (PGC)-LC [123-128]. Among them, 
RPLC is the most commonly used, due to its robustness and reproducibility. RPLC also 
does not require the use of nonvolatile salts or other buffer additives in its mobile phase, 




noncovalent interactions between its nonpolar moiety and the hydrophobic stationary 
phase. Therefore, hydrophilic glycans must be derivatized before they are suitable for 
RPLC analysis. This can be accomplished by introducing a hydrophobic tag via reductive 
amination or hydrazide labeling targeting the reducing end, but this derivatization 
strategy is not applicable towards reduced sugars, such as O-linked glycans released via 
reductive alkaline β-elimination. Alternatively, the hydrophobicity of glycans may be 
increased by permethylation. Permethylation also improves the ionization efficiency and 
gas-phase stability of labile glycans, facilitates differentiation of terminal and internal 
glycosidic fragments, and minimizes gas-phase structural rearrangements. Reduction is 
often performed in conjunction with permethylation to eliminate anomerism that leads to 
chromatographic peak splitting, which divides ion signals and complicates isomer 
separation [115]. 
 
RPLC-MS/MS and MSn analyses of permethylated glycans were first reported by Vouros 
and coworkers [223]. With low energy, on-resonance collision-induced dissociation 
(CID) as the fragmentation mode, it was not always possible to obtain complete sequence 
coverage, and the authors acknowledged the need to perform additional MSn for linkage 
determination. The chromatographic resolution was limited, and no isomer separation 
was shown. In 2013, Ritamo and coworkers showed that, by raising the column 
temperature, increased resolution can be attained, allowing separation of reduced and 
permethylated glycan isomers by RPLC [115]. They further demonstrated that a pair of 




differentiated by CID or higher-energy collisional dissociation (HCD)-MS/MS. The 
authors cautioned that the fragmentation data did not provide sufficient information to 
fully define the putative structures proposed. Three years later, when Mechref and 
coworkers again reported improved isomer resolution by RPLC at elevated temperatures 
[221], they attributed such improvement to the unfolding of the glycan structures at 
higher temperatures, allowing more effective interactions between the analyte and the 
stationary phase. Additionally, heating reduces diversity in the three-dimensional 
structures of glycans and leads to a more predictable molecular weight-retention time 
correlation, and this can facilitate identification of the glycans. 
 
Permethylated glycans can also be analyzed by PGC-LC. In 2007, Costello and 
coworkers developed a PGC-based LC-MS platform for the analysis of permethylated 
glycan alditols and demonstrated, for the first time, separation and identification of 
glycan isomers [124]. The beam-type CID employed in that study produced more 
informative tandem mass spectra than on-resonance CID, permitting determination of the 
glycan sequence, branching patterns, and even linkages in some cases. A similar 
approach was recently adopted by Mechref and coworkers, who showed improved 
resolution of isomeric glycans by higher-temperature PGC-LC [224]. Reduction and 
permethylation made it possible to distinguish between non-reducing-end-, internal-, and 
reducing-end- fragments from 16-Da mass shift of reducing-end fragments, as well as the 
number of 14-Da unmethylated “scar” created via each cleavage. Differentiation between 




large difference in their bond energies. However, the fragmentation produced by 
CID/HCD was generally too sparse to allow comprehensive structural elucidation by 
MS/MS alone. Complementary retention time information and/or alternative 
fragmentation modes may be required to make or validate details of the structural 
assignment, such as the location of the galactose residue on the 3- or the 6-arm of a 
biantennary N-glycan. 
 
Because of the tendency of CID to preferentially break the most labile glycosidic bond(s), 
the amount of structural information produced by CID in a single stage of MS/MS is 
often limited. Several groups showed that electron activated dissociation (ExD) methods, 
such as electron capture dissociation (ECD) and electron transfer dissociation (ETD), can 
generate MS/MS spectral data complementary to CID [52, 54, 61, 225]. However, ECD 
and ETD are only applicable towards multiply charged precursor ions, and they do not 
always produce complete sequence information, as the fragmentation is highly dependent 
on the nature and the binding pattern of the metal charge-carriers [56]. These limitations 
can be overcome by activating the precursor ions with higher-energy electron irradiation, 
as employed in electronic excitation dissociation (EED) [45, 189], electron ionization 
dissociation (EID) and electron impact excitation of ions from organics (EIEIO). EED, in 
particular, works with singly charged precursors and ions with a broad range of charge 
carriers, including a fixed charge [64]. The concept of EED was first introduced by 
Zubarev to describe a fragmentation process that is initiated by ionization and electron 




EIEIO, which proceeds via direct electronic and vibrational excitation [228]. EED is 
capable of producing extensive glycosidic and cross-ring fragments throughout the 
glycan sequence, for both native and derivatized glycans. Coupling of EED-MS/MS to 
on-line mobility-based separation has been achieved via selective accumulation-trapped 
IMS (SA-TIMS), and successfully applied to isomeric glycan analysis [165]. However, 
the peak capacity, throughput, and dynamic range of the SA-TIMS-EED-MS/MS 
approach still need to be improved before this approach can be efficiently applied to the 
analysis of complex biological samples. A more advantageous approach is Gated-TIMS-
EED-MS/MS, which is discussed in detail in Chapter 3 of this thesis. 
 
The feasibility of on-line RPLC–EED-MS/MS analysis on a mixture of reduced and 
permethylated maltodextrin oligomers has previously been demonstrated in our 
laboratory [45]. Here, we are applying RPLC–EED-MS/MS to characterize isomeric 
glycan mixtures. Analysis of such mixtures poses a far greater challenge than a 
maltodextrin ladder, as it requires both higher chromatographic resolution for isomer 
separation and efficient EED fragmentation that can produce diagnostic ions for each 
isomer. We present the current benchmark and discuss ways to further improve the 
method towards the ultimate goal of comprehensive, high-throughput glycome 
characterization. 
 





Lacto-N-tetraose (LNT), lacto-N-neotetraose (LNnT), and lacto-N-fucopentaose I, II, and 
III (LNFP I, II, and III) were acquired from V-Labs, Inc. (Covington, LA). LNFP V and 
VI were purchased from Carbosynth Limited (Berkshire, UK). HPLC grade water, 
acetonitrile, chloroform, and formic acid were obtained from Fisher Scientific 
(Pittsburgh, PA). Iodomethane, dimethyl sulfoxide (DMSO), sodium acetate, sodium 
borohydride (NaBH4), sodium borodeuteride (NaBD4), and acetic acid were purchased 
from Sigma-Aldrich (St. Louis, MO). 
 
4.2.2 Sample preparation 
For reduction (or deutero-reduction), 2 μg of native glycans were dissolved in 200 μL of 
0.1 M NH4OH/0.25 M NaBH4 (or NaBD4) solution for 2 hr at room temperature. Acetic 
acid (10%) was added drop-by-drop until bubbling ceased. Reduced glycans were 
permethylated using the method developed by Ciucanu and Kerek with slight 
modifications [110, 124, 229]. Dried reduced glycan powders were resuspended in 100 
μL of NaOH/DMSO mixture and vortexed for 1 hr at room temperature, followed by 
addition of 50 μL of iodomethane and 1 hr of gentle vortexing in the dark. Another 100 
μL of NaOH/DMSO and 50 μL of methyl iodide were added to the reaction mixture, and 
the reaction was allowed to proceed for 1 hr with vortexing. This process was repeated 
four times to ensure complete methylation, followed by addition of 200 μL of chloroform 
to quench the reaction. Excess salt was removed by washing with 400 μL of water, 




permethylated glycans were recovered in the organic layer, which was taken to dryness 
with a SpeedVac system (ThermoFisher Scientific). 
 
4.2.3 LC–MS/MS analysis 
On-line RPLC separation was carried out on a nanoACQUITY UPLC system (Waters, 
Milford, MA). A nanoACQUITY UPLC 2G-VMTrap column (5 μm Symmetry C18, 180 
μm ID × 20 mm) was used as the trapping column, and a nanoACQUITY UPLC Peptide 
BEH C18 column (1.7 μm, 150 μm ID × 100 mm) was used as the analytical column, 
with the temperature kept at 60 °C for improved chromatographic performance. Mobile 
phase A consisted of 99% water, 1% acetonitrile, and 0.1% formic acid, and mobile 
phase B consisted of 1% water, 99% acetonitrile, and 0.1% formic acid. In the first 2 min, 
on-line desalting was carried out using the trapping column with 2% B at a flow rate of 4 
μL/min. The analytical gradient started at 38% B for 2 min and was ramped linearly to 
42% B over the next 46 min. It was then ramped up to 80% B within 2 min and the 
mobile phase was maintained at 80% B for 4 min before being dropped to 2% B over 2 
min for column re-equilibration. MS/MS analyses were performed on a 12-T solariX 
hybrid Qh-Fourier-transform ion cyclotron resonance mass spectrometer (Bruker 
Daltonics, Bremen, Germany) equipped with an Advion Triversa nanoMate system 
(Ithaca, NY). Glycan standards were introduced into the mass spectrometer either via 
direct infusion at ~5 pmol/μL concentration or through LC (2 pmol per injection). Off-
line CID experiments were conducted with the collision energy set at 47 eV. On-line LC–




an electron irradiation time of 0.5 s. Auto MS/MS was performed with alternating MS 
scan and (two) MS/MS scans. An inclusion list was used without dynamic exclusion to 
allow the sodiated precursor ions be repeatedly selected for fragmentation. A 0.5-s 
transient was acquired for each mass spectrum. For each LC–MS/MS run, a single 
MS/MS spectrum was chosen for internal calibration, using several fragments assigned 
with high confidence, typically Y-, Z-, and 1,5X-ions. The same calibration constants were 
then automatically applied to all mass spectra acquired on the same LC run, resulting in a 
typical mass assignment accuracy of < 1 ppm. Peak picking was performed using the 
SNAP algorithm (Bruker Daltonics, Bremen, Germany) with the quality factor threshold 
set at 0.1, S/N cutoff at 5, maximum charge at 4, and a relative ion abundance threshold 
at 0.01%. Peak assignment was achieved manually with the assistance of a custom VBA 
(Visual Basic for Applications) program (Microsoft, Seattle, WA), and ChemDraw 15.0 
(PerkinElmer, Waltham, MA). 
 
4.3 Results and discussion 
Two sets of isomeric glycan standards were studied. The first set contains two linear 
tetrasaccharide isomers, LNT (Galβ1→3GlcNAcβ1→3Galβ1→4Glc) and LNnT 
(Galβ1→4GlcNAcβ1→3Galβ1→4Glc), that differ in only one linkage position. The 
second set includes five pentasaccharide isomers with either linear or branched structures. 
Among them, LNFP I, II, and V are topological isomers resulting from the addition of a 
fucose (Fuc) residue to the LNT structure, at the non-reducing-end Gal, GlcNAc, and the 




structure and are linkage isomers to LNFP II and V, respectively. All glycans were 
reduced and permethylated before LC–MS/MS analysis. 
 
Figure 4.1 Glycan standards used in this study. 
 
4.3.1 NanoLC–MS/MS analysis of reduced and permethylated LNT and LNnT 
It is advantageous to analyze glycans in their metal adducted forms, as the intact species 
to be more stable and, when they are induced to dissociate, they produce a wider variety 
of product ions than are obtained from protonated species, which undergo glycosidic 
cleavages so readily that few cross-ring products are observed. Furthermore, protonated 
glycans are subject to gas-phase structural rearrangements, even after permethylation, and 
this can lead to erroneous structural determination [230-236]. In RPLC, however, eluted 
glycans are most commonly ionized via protonation or ammonium adduction, with 
ammonium adducts readily converted to protonated species upon collision-induced 
dissociation. It has been shown that formation of sodium adducts can be promoted by 
adding sodium acetate to the mobile phase [115, 237], or by spiking a high concentration 
of sodium salt into the glycan sample before injection [224]. Here, we adopted the latter 
LNT LNnT




approach to avoid continuous flow of sodium salt into the mass spectrometer and the 
need for frequent ion source cleaning, as the majority of the salt added to the sample went 
to waste during the trapping before LC separation. Figure 4.2 shows a mass spectrum 
from an LC-MS run of a mixture of LNT and LNnT, with pre-injection incubation in 25 
mM of sodium acetate for 3 min with vortex mixing. Sodium adducts are the most 
abundant ions detected; some protonated species and ammonium adducts are also present. 
For analysis of biological samples, to mitigate signal dilution and to improve detection 
sensitivities, further concentrating the ion signals into sodium-adducts via addition of 
sodium salt to the mobile phase may be necessary. 
 
Figure 4.2 A typical mass spectrum acquired during an LC-MS run of a mixture of reduced and 
permethylated LNT and LNnT. With addition of 25 mM sodium acetate prior to sample injection, 
sodium adducts are the most abundant species observed. Some protonated species and ammonium 







































Figure 4.3a shows the extracted ion chromatogram (EICs) of a mixture of reduced and 
permethylated LNT and LNnT ([M + Na]+ m/z 942.4880). The two linkage isomers were 
baseline resolved by nanoRPLC (C18), with each exhibiting a single peak, as expected 
for reduced glycans. Figure 4.3b and c show EED spectra acquired at retention times near 
the peak of elution for each isomer. Complete series of Z-, Y-, and 1,5X-ions are observed 
in both EED spectra, and they form triplets with characteristic spacing: 18.011 Da (H2O) 
between the neighboring Z- and Y-ions and 27.995 Da (CO) between the adjacent Y- and 
1,5X-ions. Those are similar to what were observed in EED of glycans with a reducing-
end fixed charge label [64]. Here, without the fixed charge label on the reducing-end, 
many more non-reducing-end fragments are observed. For example, near complete series 
of 1,5A-, B-, and C-ion triplets are present in the spectra, but with the spacing in reversed 
order, and this allows differentiation of non-reducing-end and reducing-end fragments. 






Figure 4.3 On-line nanoRPLC‒EED-MS/MS (16 eV) analysis of a mixture of reduced and 
permethylated LNT and LNnT. (a) EIC of the precursor ion, [M+Na]+, m/z 942.4880. (b, c) EED 
spectra acquired near the peak of elution for each separated isomer, as marked by retention time 
and corresponding structure. 
 
It has been suggested that EED proceeds, via an ionization/electron recapture mechanism, 
through an open-ring di-radical intermediate, with the C1-C2 di-radical being 
energetically favored due to the stabilization of the C1 radical by the glycosidic and ring 
oxygen atoms [238]. Proposed reaction pathways from various di-radicals to B•, C•, Y•, 
Z•, 1,5A••, and 1,5X ions are shown in Scheme 4.1. The B•, Z•, C• and Y• fragments can 






















































































































































































































































































subsequently lose a hydrogen radical in the alpha position to form even-electron B, Z, C‡, 
Y‡ ions, respectively. Intramolecular hydrogen transfer before product separation may 
also occur, leading to the formation of C and Y ions from C• and Y•. The 1,5A•• di-radical 
can either lose two alpha hydrogens to form a stable 1,5A-2H (or 1,5A‡) ion, or form a 
closed-ring 1,5A ion via radical recombination. The 1,5X ions are formed as stable closed-
ring species, and are often among the most abundant ions observed in the EED spectra. 
Because EED is primarily a radical-driven process, it is capable of generating extensive 
fragmentation throughout the glycan sequence. In contrast, glycan CID tandem mass 
spectra are often dominated by a few fragments resulting from the cleavage of the most 
labile glycosidic bonds. 
 











Whereas the presence of glycosidic and 1,5-cross-ring fragments allows accurate 
elucidation of the glycan sequence (topology), they provide no information on the linkage 
positions. For tandem MS-based glycan structural characterization, linkages have usually 
been inferred from the presence and/or absence of diagnostic cross-ring fragments. In an 
earlier study of those two linkage isomers in their permethylated form, the linkage-
informative 3,5A2 ion (m/z 329.157) was observed for the 1→4-linked LNnT, whereas 
1,3A2 ion (m/z 356.168) were found in the spectrum of 1→3-linked LNT, , allowing 
differentiation of the two isomers [165]. 
 
Because the LNT-specific 1,3A2 ion is too low in abundance for reliable linkage 
assignment, other regions of the EED spectra were examined in search of linkage-
diagnostic fragments. One such region was found to be populated with several secondary 
fragments from Z3
•. For the later eluting species, presumably LNT, a Z3
•-NCH3Ac ion 
(m/z 635.324, S/N 42) was observed. This ion was likely generated when direct alpha 
cleavage from the C3 radical led to the loss of the entire C2 substituent (Scheme 4.2a), 
and thus it could be considered diagnostic for the 1→3-linked GlcNAc residue. Another 
diagnostic ion for LNT is 0,4X2/Z3 (m/z 634.340, S/N 164), which was likely produced 
from the C3 radical via consecutive alpha cleavages, followed by intramolecular H 
transfer (Scheme 4.2b). Although the m/z values calculated for Z3
•-NCH3Ac and the A+1 
isotope peak of 0,4X2/Z3 differ by only 0.019 Da, these two peaks can be easily 




consecutive alpha cleavages from the C4 radical would result in the formation of a Z3
•-Ac 
ion (Scheme 4.2c). The Z3
•-Ac ion (m/z 664.352, S/N 150) is indeed observed in the EED 
spectrum of the first eluting species, presumably LNnT. However, unlike the Z3
•-
NCH3Ac ion, which is only observed in the LNT spectrum, the 
0,4X2/Z3 and Z3
•-Ac ions 
are present in both EED spectra. Formation of 0,4X2/Z3 in LNnT and Z3
•-Ac in LNT likely 
follows radical migration (via 1,2-H migration) prior to alpha cleavages, and this process 
is associated with a considerable activation barrier [56]. Therefore, the abundance ratio of 
0,4X2/Z3 to Z3
•-Ac shows substantial difference, ranging from 0.6 in the LNnT spectrum 






Scheme 4.2 Proposed EED mechanisms for the formation of linkage-diagnostic Z•-NCH3Ac, 
0,4X/Z, Z•-Ac, and C/Z ions. 
 
Other types of secondary fragments from Z• ions were also generated, including Z•-CH3, 
Z•-OCH3, and Z
•-CH2OCH3, via alpha cleavages to lose substituent at the neighboring 
carbon. It was previously reported that for native glycans, Z•-CH2OH is preferentially 
formed at 1→4-linked residues (loss of the C6 substituent), whereas Z•-OH is the favored 













C6 substituent, leading to the formation of Z•-CH2OCH3, at 1→4-linked sites is not 
observed. Given that a methoxy radical (∙OCH3) is far more stable than a hydroxyl radical 
(∙OH) due to the hyperconjugative interactions between the methyl group and the 
oxygen-based radical [239]. Thus, loss of the C3 substituent (Z•-OCH3) from a C4 radical 
competes more favorably with loss of the C6 substituent (Z•-CH2OCH3) in permethylated 
glycans than in native glycans (Z•-OH versus Z•-CH2OH). Nevertheless, it appears that 
the abundance ratio of Z3
•-CH2OCH3 to Z3
•-OCH3 is still far higher in the LNnT 
spectrum than in the LNT spectrum. Therefore, the general trend that it is easier to lose 
the C6 substituent from a C4 radical than from a C3 radical still holds true for 
permethylated glycans, and such knowledge can be useful for relative abundance-based 
linkage determinations. 
 
Another ion of interest is m/z 268.115. This ion has been tentatively assigned as an 
internal fragment of C2/Z3. Scheme 4.2d shows the proposed mechanism for the 
formation of C2/Z3 via direct alpha cleavages from the C1–C2 di-radical at the GlcNAc 
site in LNT. For LNnT, the formation of C2/Z3 requires radical migration. Consequently, 
the relative abundance of the C2/Z3 ion in the LNnT spectrum is 38 times lower than that 
in the LNT spectrum. Note that the C2/Z3 ion is essentially an internal HexNAc (N-
acetylhexosamine) ion; thus, its prominent presence only indicates the existence of a 
1→3-linked HexNAc residue, but does not specify its location within the glycan 




studied here, the propensity for formation of the HexNAc internal ion can serve as an 
additional indicator for differentiation of LNT and LNnT. 
 
4.3.2 NanoLC–MS/MS analysis of reduced and permethylated LNFPs 
Figure 4.4a shows the EIC of the precursor ion (m/z 1117.5835, [M+Na]+) from an LC–
MS analysis of a mixture of reduced and permethylated LNFP I, II, III, V, and VI (black 
trace), as well as the overlaid EICs of the same precursor from LC-MS analyses of each 
individual isomer. With five isomers eluting within a 7-min window, some isomers were 
only partially resolved. In particular, the elution profiles of the linkage isomers LNFP II 
and III have significant overlap, resulting in a broad peak centering around an R.T. of 
33.6 min. In Figure 4.5, sections a-e show the EED spectra acquired at five different 
retention times, including two acquired at the rising (R.T. 33.10 min) and falling edges 
(R.T. 34.17 min) of the unresolved peak. Nonetheless, these five spectra exhibited 
considerable differences in their fragmentation patterns and can be used to assign the 
structure at each elution time. These assignments are consistent with the elution profiles 





Figure 4.4 On-line nanoRPLC‒EED-MS/MS analysis (18 eV) of a mixture of reduced and 
permethylated LNFP glycans. Vertical dashed lines mark the time points when EED spectra were 
acquired. (a) Black trace: EIC of the precursor ion, [M+Na]+, m/z 1117.5835. Overlaid colored 
traces: EICs of the precursor ion from LC runs of individual standards. (b) Y (FucGalGlc) ions 
were produced only when LNFP VI and V were eluting. (c) C/Z (GlcNAc) ions were produced 
only when LNFP I and V were eluting. (d) C/Z (FucGlcNAc) ions were produced only when 




































































could also be produced in LNFP I and V via radical migration. LNFP VI can produce a C2α•-
OCH3 ion that has the same m/z value as the C/Z (GalGlcNAc) ion. The oscillations in the EICs 
are caused by switching between the MS and MS/MS acquisition modes. 
 
Rather than trying to present an interpretation for every single peak in the LNFP spectra, 
we focus our discussion below on fragments that are important for isomer differentiation. 
For topology analysis, complete series of Z-, Y-, and 1,5X-triplets (labeled in orange) are 
present in all LNFP spectra, as are the majority of 1,5A-, B-, and C-ions. One 
complicating factor for topology analysis of branched structures is the presence of 
internal fragments resulting from the loss of more than one of the non-reducing-end 
branches. These are mainly Z/Z-ions, produced via β-elimination of an entire non-
reducing-end branch from Z• radicals [64, 240]. Z/Z-ions are most frequently observed at 
the branching sites, and the appearance of high-abundance Z/Z-ions could facilitate 
determination of the branching pattern. Importantly, internal fragments do not share the 
same contextual features as reducing-end glycosidic fragments, and they can be easily 
differentiated from terminal fragments based on their peak contexts. In addition, the 
number of hydroxyl groups (un-methylated scars) resulting from the hydrogen transfers 
that accompany glycosidic bond cleavages can also be used to differentiate terminal and 
internal fragments. 
 
A potential issue in MS/MS-based glycan sequencing is the occurrence of gas-phase 




observed in the form of fucose migration. Although it is reported that permethylation and 
metal adduction largely eliminate structural rearrangements in gas phase, it is important 
to examine whether this is true in EED. One way is to probe EED spectra acquired when 
each of isomer elutes from the LC column (Figure 4.5); however, this is not the best 
approach and could bring potential misinterpretation. For example, LNFP V- and VI-
specific Y2α ions (m/z 654.341) are also observed in the EED spectra of LNFP II and III, 
and these might be misinterpreted as evidence for the existence of fucose migration. The 
true explanation underlying this observation is that the elution profiles of the five isomers 
overlapped somewhat. A more convincing way to gauge whether, and to what extent, 
structural rearrangement has taken place is to compare the EICs of diagnostic fragments 
of each individual isomer (Figure 4.4b-e). Figure 4.4b shows the EIC at m/z 654.341 
aligned with the EIC of precursors. From that, it is clear that the ion at m/z 654.341 
observed in the EED spectra of LNFP III originated from the co-eluting LNFP VI and its 
occurrence in the spectrum of LNFP II was due to tailing of the peak from LNFP V, as 
the EIC follows closely the elution profiles of LNFP VI and V, with a nearly flat baseline 
within the retention time windows when only LNFP III and II were eluting. Therefore, 
there is no convincing evidence for gas-phase structural rearrangement of the isomers 





Figure 4.5 EED spectra of LNFP glycans acquired at five different elution times as marked in 
Figure 4.4, with the major eluting species shown on the top left of each panel. 
 
For linkage analysis, the 3,5A2α and 
3,5A2 ions (m/z 329.157) diagnostic for the 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































III, respectively. For the LNT-derived LNFP isomers, the Gal1→3GlcNAc linkage-
specific 1,3A3 ion (m/z 530.257) is observed only in the LNFP I spectrum, whereas the 
1,3A2 ions (m/z 356.168) have very low abundances, and the SNAP algorithm failed to 
assign these ions in the EED spectra of LNFP V and II because the A+1 isotopic peak 
was not detected. Although diagnostic cross-ring fragments are not always present in 
EED spectra, other internal and secondary fragments can assist with linkage assignment. 
As in the EED spectrum of LNT, a high-abundance C/Z (GlcNAc) internal fragment (m/z 
268.115) is observed in the EED spectra of LNFP I (C3/Z3) and V (C2α/Z3α), which both 
contain a 1→3-linked GlcNAc residue; in the EED spectra of LNFP I and V, these peaks 
have S/N ratios of 149 and 154, respectively. For LNFP VI, with a 1→4-linked GlcNAc, 
the C2α/Z3α ion was generated at a much lower abundance and its S/N ratio was only 15. 
For LNFP II and III, where GlcNAc is present at a branched site, loss of the C3 
substituent generated a C2/Z3α ion (m/z 442.205, S/N 550) and a C2/Z3β ion (m/z 472.215, 
S/N 479), respectively, both with the C4 substituent still attached. For these isomers, loss 
of the C4 substituent via radical migration is also possible, but occurred to a much lower 
degree. Therefore, the abundant C/Z internal fragments produced under EED condition 
can be treated as diagnostic fragments for 1→3 linkage determination. For glycans with 
multiple GlcNAc residues, so long as they have different C4 and C6 substituents, the C3 
branch can also be determined at each site based on the presence of C/Z internal ions. 





For site-specific linkage determination, secondary fragments generated from Z• ions were 
found to be informative. In the case of LNT/LNnT, we showed above that Z•-NCH3Ac is 
a diagnostic fragment for a 1→3-linked GlcNAc residue. This also appears to hold true 
for the LNFP glycans. In LNFP II and V, where the C3 substituent at the GlcNAc site is a 
Gal residue, EED generated a Z3α
•-NCH3Ac ion (m/z 810.420); for LNFP III with a Fuc 
residue as the C3 substituent, EED produced a Z3β
•-NCH3Ac ion (m/z 840.432); for LNFP 
I with Fuc-Gal as the C3 substituent, EED produced a Z3
•-NCH3Ac ion (m/z 636.332); 
and for LNFP VI with no C3 substituent, no Z•-NCH3Ac ion was detected. On the other 
hand, although the abundance ratio of Z3α
•-CH2OCH3 (m/z 837.431) to Z3α
•-OCH3 (m/z 
851.447) is still higher in LNFP VI (0.31) and III (0.31) than in LNFPV (0.10) and II 
(0.24), such a small difference has little diagnostic value for linkage analysis. 
 
The discussion thus far has been focused on the differentiation of 1→3- and 1→4-
linkages. As the last example here, we turn our attention to the only 1→2-linkage site 
present in these glycan standards, the Fuc1→2Gal moiety in LNFP I. Positive 
identification of the 1→2-linkage is very difficult by MS/MS, since it does not produce 
any unique cross-ring fragment that cannot also be generated by a 1→3-linkage. In 
principle, we could infer 1→2-linkage based on the absence of 0,2X ion, because 0,2-
cross-ring cleavage does not break 1→2-linked glycosidic bond. However, linkage 
determination via negative inference is not persuasive, especially since the abundances of 
0,2X ions produced at non-1→2-linked sites are usually quite low. We note that there is a 
high abundance of the C2




spectrum; this could be produced via loss of the C3 substituent from the C1–C2 di-
radical, as shown in Scheme 4.3a. For 1→3-linked hexose, occurrence of the same 
fragmentation pathway would generate a C/Z (Hex) internal ion. The C1–C2 di-radical 
can also produce a C/Y (Hex) internal ion at a 1→2-linked site (Scheme 4.3b). This C/Y 
internal ion is not characteristic of any other linkage configuration. Together, these two 
fragments provide strong, positive evidence for the 1→2-linkage assignment. We should 
caution that C•-OCH3 may also be produced at 1→3-linkage sites via radical migration, 
but, when present, it usually has very low abundance. Accordingly, by taking into 
consideration the propensity of all these diagnostic, but not necessarily unique, ions, the 
1→2 linkage assignment can be far more reliably achieved than by inference from cross-
ring fragments alone. 
 











In this study, the potential of nanoRPLC–EED-MS/MS for characterization of isomeric 
glycan mixtures was investigated. The results showed that up to five isomeric species, 
including both linear and branched structures, could be at least partially resolved and 
characterized in a single LC-MS/MS run. For the two linkage isomers with significant 
overlap in their elution profiles, it was still possible to determine their presence and 
elucidate their structures by examining the EED spectra acquired at the rising and falling 
edges of the overlapped chromatographic peak. Compared with CID, EED generated far 
more structurally informative fragments. Translating these complex glycan EED tandem 
mass spectra into structures requires a sound understanding of the fragmentation process. 
The results presented here show that the formation of most fragment ions, as well as their 
relative abundances, can be explained within the frame of the ionization/electron 
recapture mechanism and fundamental radical chemistry. For all glycan standards 
studied, EED was able to cleave every single glycosidic bond, generating complete C-, 
Y-, and Z-ion series with distinctive peak contexts for each fragment type, allowing 
accurate glycan topology elucidation from the first principle. We further demonstrated a 
new strategy for glycan sequencing that deduces linkages based on the propensity of a 
combination of diagnostic cross-ring, secondary, and internal fragments. 
 
The current study represents an important step towards the development of a LC–EED-
MS/MS approach for comprehensive glycome characterization, although several 
challenges remain before it can be routinely applied to analysis of biological samples. 




contamination by fragments from co-eluting isomers. We will implement EED with on-
line PGC-LC separation in the next step as PGC-LC is one of the best chromatographic 
methods for resolving isomeric structures. Second, for complex biological samples, it is 
likely that some isomeric glycans will remain incompletely resolved, even on PGC-LC. 
Partially resolved chromatographic peaks can be deconvoluted by principal component 
analysis (PCA) at the MS2 level [241, 242]. Third, there will be a need to acquire and 
analyze a large number of EED spectra of glycans that include structures with a variety of 
residues, branching patterns, and linkage configurations, from which, the performance of 
EED in detailed glycan structural analysis will be evaluated and better understood. In 
addition to that, a comprehensive training dataset may be generated for the construction 
of a universal LinkageClassifier [176] that would ultimately allow fully automated 




Chapter 5: PGC-LC–EED-MS/MS analysis of N-linked and O-linked glycans 
5.1 Introduction 
Glycosylation is one of the most important co- and post-translational modifications in 
eukaryotic proteins. It has been reported that more than 50% of human proteins are 
glycosylated, among which, N-glycosylation and O-glycosylation are the most common 
types, with the most abundant glycoprotein class being the immunoglobulins [243, 244]. 
Alterations of protein glycosylation characterize a variety of diseases [245, 246], making 
these modifications valuable candidates for recognition as biomarkers [247]. Though 
many research efforts have contributed to analysis of protein glycosylation, complete 
structural elucidation by mass spectrometry is still a challenging task. This is due partly 
to the structural complexities of glycans, and the flexibility of their bio-synthetic 
pathways. Unlike peptides or oligonucleotides, changes of glycan structures result not 
only from variations in the monosaccharide compositions or sequences, but, more 
interestingly, from a multitude of possible linkages. In contrast to the elaboration of the 
proteome or genome, there is no direct genetic control of carbohydrate synthesis [248], 
and this further increases the potential range of glycan structures. The co-occurrence of 
numerous structural isomers among the glycans present in individual biological sources 
presents a severe challenge for structural glycomics. The subtle differences among 
isomeric structures demand analytical methods that can provide extensive structural 





To date, a variety of LC-MS/MS based methods and databases have been developed to 
facilitate rapid structural analysis of protein glycosylation [249-251]. However, each of 
these has some constraints or limitations, particularly with regard to precise 
determination of linkages between the monosaccharide components. Most existing 
MS/MS approaches center on the use of collision-induced dissociation, which primarily 
cleaves fragile glycosidic bonds, and thus they produce linkage-diagnostic fragments 
with only low efficiency. Sequential exoglycosidase digestions can assist linkage analysis 
in existing methods, but it is complicated, time consuming, expensive and may not fully 
elucidate glycan linkages. Moreover, most existing methods rely on databases that 
include only the previously identified glycoforms, and thus are not adequate for de novo 
sequencing to identify novel structures. 
 
At present, a truly facile method for rapid and detailed de novo glycan structural 
characterization is urgently needed. In this study, we have advanced toward the goal of 
rapid and comprehensive glycan structure elucidation. First, as initially discussed in 
Chapter 2, we refined the fragmentation method of electronic excitation dissociation 
(EED) and have utilized it to produce much more informative glycan tandem mass 
spectra than CID or HCD, thereby allowing accurate topology and linkage determination 
at the same time. Second, as introduced in Chapter 2 and discussed more fully in this 
Chapter, we have implemented EED MS/MS with on-line nanoPGC-LC separation, as 
this achieves the best performance in isomer separation [124, 126, 128]. Third, as shown 




facilitate structure determination, such as deutero-reduction, permethylation, offline 
fractionation & enrichment, and sialic acid linkage-specific amidation [110-112]. Overall, 
the results achieved to date, made possible through the refinement and combination of 
these approaches, provide strong evidence for the significant contributions our methods 
can make towards reaching the goal of truly de novo and comprehensive glycome 
characterization. 
 
5.2 Experimental section 
5.2.1 Materials 
PNGase F was acquired from New England BioLabs (Ipswich, MA). Human blood 
serum, bovine submaxillary mucin, iodomethane, dimethyl sulfoxide (DMSO), 
dimethylamine, N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC), 
1-hydroxybenzotriazole (HOBt), sodium acetate, sodium borodeuteride (NaBD4), 
ammonium bicarbonate (ABC), dithiothreitol (DTT) and acetic acid were purchased from 
Sigma-Aldrich (St. Louis, MO). HPLC-grade water, acetonitrile (ACN), isopropyl 
alcohol (IPA), chloroform, and formic acid were obtained from Fisher Scientific 
(Pittsburgh, PA). C18 Sep-Pak cartridges were obtained from Waters (Milford, MA). 
HyperSep Hypercarb SPE cartridges were purchased from Thermo Fisher Scientific 
(Waltham, MA). 
 




N-linked glycans were released from human blood serum using PNGase F [252]. Briefly, 
10 μL of human serum was diluted in 40 μL of water, then centrifuged at 13,000 rpm for 
20 min. The supernatant was transferred to a new vial. Ammonium bicarbonate (ABC) 
(100 mM, 146 μL) and 2 μL of 200 mM DTT were added before incubation at 60 oC for 
40 min. Next, a 2-μL aliquot of the PNGase F solution was added and the mixture was 
incubated at 37 oC for 16 hr. 
 
The released N-linked glycans were purified using C18 Sep-Pak cartridges. Briefly, after 
PNGase F treatment, the mixture was passed three times through a C18 cartridge. After 
that, the cartridges were washed three times with 100 μL 5% ACN. All eluents from the 
C18 cartridges were combined and dried in a SpeedVac system. 
 
For deutero-reduction, dried glycans were dissolved in 200 μL of 0.1 M NH4OH/0.25 M 
NaBD4 solution for 2 hr at room temperature. Acetic acid (10%) was added drop-by-drop 
until bubbling ceased. Reduced glycans were permethylated using the method developed 
by Ciucanu and Kerek with slight modifications [110, 124, 229]. Briefly, the reduced and 
dried glycan powders were resuspended in 100 μL of NaOH/DMSO mixture and 
vortexed for 1 hr at room temperature, followed by addition of 50 μL of iodomethane and 
1 hr of gentle vortexing in the dark. Another 100 μL of NaOH/DMSO and 50 μL of 
methyl iodide were added to the reaction mixture, and the reaction was allowed to 
proceed for 1 hr with vortexing. This process was repeated three times to ensure complete 




Excess salt was removed by washing with 400 μL of water several times, until neutral pH 
was reached. The aqueous layer was discarded, and the permethylated glycans were 
recovered in the organic layer, and dried with a SpeedVac system. 
 
5.2.3 Linkage-specific dimethyl-amidation of sialylated glycans 
Dried native glycans were dissolved in the optimal dimethyl-amidation reagent (20 μL of 
250 mM EDC, 500 mM HOBt, and 250 mM dimethylamine in DMSO) and incubated at 
60 oC for 3 hr [111, 112]. The derivatized glycans were purified by PD MiniTrap G-10 
columns (GE Healthcare, Buckinghamshire, UK) according to the included instruction, 
followed by reduction and permethylation. 
 
5.2.4 Release, purification, and permethylation of O-glycans 
O-linked glycans were released from bovine submaxillary mucin via reductive alkaline β-
elimination [108]. Briefly, 1 mg of mucin power was dissolved in 400 μL aqueous 50 
mM NaOH and 50 mM NaBD4, and incubated at 45 
oC for 16 hr. After that, the reaction 
was terminated by dropwise addition of 10% acetic acid until bubbling ceased. 
 
The released O-linked glycans were purified using C18 Sep-Pak cartridges. Briefly, the 
mixture was passed through a C18 cartridge three times and then the cartridge was 
washed three times with 100 μL 5% ACN. All eluents from C18 cartridges were 
combined and dried in a SpeedVac system. The dried O-linked glycans were 





5.2.5 LC–MS/MS analysis 
On-line liquid chromatographic separation of the permethylated glycans was carried out 
on a Waters nanoACQUITY UPLC system (Milford, MA). A nanoACQUITY UPLC 2G-
VMTrap column (5 μm, Symmetry C18, 180 μm ID × 20 mm) was used as the trapping 
column, and a Hypercarb nanoPGC column (3 μm, 75 μm ID × 100 mm) was used as the 
analytical column, with the temperature kept at 60 ᵒC. Mobile phase A consisted of 99% 
water, 1% ACN, 0.1% formic acid. Mobile phase B consisted of 50% ACN, 50% IPA, 
0.1% formic acid. In the first 2 min, on-line desalting was carried out in the trapping 
column with 10% B at a flow rate of 4 μL/min. The analytical gradient started at 35% B 
for 5 min and then ramped linearly to 95% B over the following 60 min. 
 
MS/MS analyses were performed on a 12-T solariX hybrid Qh-Fourier-transform ion 
cyclotron resonance mass spectrometer (Bruker Daltonics, Bremen, Germany). On-line 
nanoLC–EED-MS/MS analysis was performed with the cathode bias set at 18 V, and an 
electron irradiation time of 0.5 s. Auto MS/MS was performed with alternating MS and 
MS/MS scans. An inclusion list was used without dynamic exclusion to allow the 
sodiated precursor ions be repeatedly selected for fragmentation. A 0.5-s transient was 
acquired for each mass spectrum. 
 




Offline fractionation of permethylated glycans prior to on-line analysis was conducted on 
a Waters ACQUITY UPLC system (Milford, MA). An ACQUITY UPLC BEH column 
(1.7 μm, C18, 1 mm ID × 100 mm) was used to separate different glycoforms based on 
their hydrophobicity. An Advion Triversa nanoMate system (Ithaca, NY) was used to 
collect fractions every 30 s, from 10 min to 60 min. Fractions were dried by a SpeedVac 
system, before on-line analysis by nanoPGC-LC–EED-MS/MS. 
 
5.3 Results and discussion 
As reported previously by our laboratory, it is advantageous to fragment and analyze 
glycans in their metal-adducted forms [189, 232], because metal-adducted glycans tend to 
generate more extensive fragmentation without gas-phase structural rearrangement 
induced by mobile proton. With the spiking of 200 mM sodium acetate into the glycan 
sample before injection, sodium adducts were detected as the most abundant ions. 
 
NanoPGC-LC–EED-MS/MS analysis was performed on the deutero-reduced and 
permethylated N-linked glycans released from human blood serum and O-linked glycans 
released from bovine submaxillary mucin. Due to the excellent separation power of PGC-
LC, almost all glycoforms and isomers were baseline resolved, thus allowing detailed 
structural analysis of each individual glycoform. EED was chosen as the primary 
fragmentation method due to its ability to produce a wide variety of fragments for glycan 
topology and linkage analysis, as demonstrated in our previous study [64, 189]. Glycan 




and linkage-independent cross-ring 1,5X-ions; they were often produced in sets with 
characteristic spacing in between, and thus could be easily assigned. Linkages were 
elucidated based on the presence of several cross-ring fragments (1,3A, 3,5A and 0,4A), a 
few linkage-specific internal fragments (C/Z and C/Y), and a secondary fragment (C•-
OCH3) [253]. All of these diagnostic ions were predominantly produced, via di-radical 
intermediates, under EED conditions. The structures of these fragments and the proposed 
mechanisms for their formation are shown in Figure 5.1. Briefly, 1,3A (Figure 5.1a) is 
unique for 1→2 and 1→3 linkages, 3,5A (Figure 5.1b) for 1→4 and 1→6 linkages, and 
0,4A (Figure 5.1c) for 1→6 linkage only. The observation of C/Z cleavages on the same 
saccharide residue indicates its 1→3 linkage (Figure 5.1d), whereas C/Y is a fragment 
unique to the 1→2 linkage (Figure 5.1e). Each of these ions is characteristic of certain 
linkage configurations. Combining information provided by these ions allows confident 





Figure 5.1 Linkage-diagnostic fragments under EED conditions. 
 
5.3.1 PGC-LC–MS/MS analysis of N-linked oligomannose in human serum 
As shown in Figure 5.2a, ten N-linked oligomannose structures were identified; the 
extracted ion chromatograms corresponding to their intact cationized molecular ions are 
shown in Figure 5.3. Their detailed structures were determined on the basis of the EED 
spectra (Figure 5.4 a-j) acquired over the time window when each isomer eluted from the 
PGC liquid chromatograph. Among them, one isomer of Man 5, two isomers of Man 6, 
three isomers of Man 7, three isomers of Man 8, and one isomer of Man 9 were 
identified. This result is different from the oligomannose pattern previously observed in 








released from bovine Ribonuclease B. As shown by the results presented here, the 
oligomannose structures determined for the glycans released from human serum are all 
canonical structures [256]. 
 
Figure 5.2 N-linked (a) Oligomannose (b) Complex structures (c) Hybrid structures identified in 
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Figure 5.3 EICs observed for different N-linked oligomannose [M + 2Na]2+ precursor ions 
detected during on-line PGC-MS/MS analysis of N-linked glycans released by PNGase F 
treatment of human serum. 
 
Two isomers of Man 6 (Figure 5.4b1 and 5.4b2) contain the same Man 5 structure but 
differ in the position of the sixth mannose residue (Figure 5.4a). In one isomer, the extra 
mannose is attached to the β-arm that is 1→3 linked to the core mannose (Figure 5.4b1) 
and in the other, it is connected to the α′-arm (Figure 5.4b2). Their structural difference 
can be distinguished by unique 0,4A3α (m/z 709.325), 
3,5A3α (m/z 737.357), C3α/Z3β (m/z 
839.388) in the spectrum of the isomer that carried the sixth mannose on the 3-arm 
(Figure 5.4b1), and the unique fragments 3,5A4α′ (m/z 941.456), 
1,5X3α (m/z 998.500), 
C2β/Z3β (m/z 1043.488) in the spectrum of the isomer which had the additional terminal 










































these types of ions can be used to determine the residue composition of the “upper” arm 
that is attached to the core mannose via a 1→6 linkage. 
 
Similarly, by using a combination of unique 0,4A, 3,5A, C/Z, 1,5X ions and some other 
glyosidic or secondary fragments, three isomeric structures of Man 7 (Figure 5.4c1, 5.4c2 
and 5.4c3), three isomeric structures of Man 8 (Figure 5.4d1, 5.4d2 and 5.4d3) and the 





































































































































































































































































































































































































































































































































































































































































































































Figure 5.4 On-line nanoPGC-LC–EED-MS/MS analysis of deutero-reduced and permethylated 
N-linked oligosaccharide in human serum. EED spectra acquired at the peak of elution of Man 5 
(a), Man 6 (b1, b2), Man 7 (c1, c2, c3), Man 8 (d1, d2, d3), and Man 9 (e). 
 
5.3.2 PGC-LC–MS/MS analysis of N-linked complex structures 
N-linked complex structures are named based on “general nomenclature used to describe 
IgG glycans” [257]. G1F is one of several complex glycoforms commonly observed in 
the Fc region of monoclonal antibody (mAb) drugs [258]. The N-glycosylation 
heterogeneity on the conserved N297 site has crucial influence on the structural 
characteristics of the Fc region [259]. Recent studies indicate that terminal 
galactosylation could open up the Fc-part of the CH2-region, so that its configuration 
changes from a more “closed” form to a horseshoe-like structure [260]. This 
configurational change greatly influences the effector function of antibodies, due to the 
interactions of the Fc part with its receptors. Therefore, a thorough structural 
characterization regarding the terminal galactose is the first step to understand the 
functional behavior of both biological and biopharma-produced antibodies. In this study, 
two isomers of G1F were observed in human serum (Figure 5.5a), and on-line EED 































































































































MS/MS spectra, the two structures are linkage isomers. As shown in Figure 5.5b and c, 
these two isomers share many common fragments, such as B2α, 
1,5X1β, Y1α, Z1β, since they 
have the same topology. However, similar to the results we obtained for oligomannose, 
several linkage-unique cross-ring or secondary fragments were observed and could be 
used to determine the position of the terminal galactose in these two isomers. The key 
fragments for these assignments are 0,4A4α′ (m/z 750.352), 
3,5A4α′ (m/z 778.383), C4α′/Z3αʺ 
(m/z 880.416) in the EED spectrum of the first isomer (Figure 5.5b), and the 0,4A3αʺ (m/z 
546.252), 3,5A3αʺ (m/z 574.283), C3αʺ/Z3α′ (m/z 676.316) fragments in the spectrum of the 
second isomer (Figure 5.5c). These fragments are all unique to specific residue 
compositions on the 6′ arm of the core mannose (red dotted rectangle in Figure 5.5b and 
c). The mass differences between the analogous fragments in the spectra of the two 
isomers (0,4A4α′ vs. 
0,4A3αʺ, 
3,5A4α′ vs. 
3,5A3αʺ, C4α′/Z3αʺ vs. C3αʺ/Z3α′) are 204.098 u, which 
corresponds to the residue mass of one permethylated hexose. This indicates different 
residue compositions in their 6′ arms, and may be used to determine the position of the 
terminal galactose in two isomers. Similarly, by comparing certain 0,4A, 3,5A and C/Z ions 
with their precursors, the topologies and glycosidic linkage types of other complex 





Figure 5.5 On-line nanoPGC-LC–EED-MS/MS analysis of deutero-reduced and permethylated 
N-glycans in human serum. (a) EIC of G1F in human serum. (b) EED spectrum acquired at the 
maximum in the elution peak of the first isomer. (c) EED spectrum acquired at the maximum in 
the elution peak of the second isomer. 
 
N-linked glycan structures that contain a bisecting GlcNAc residue at the C4 position of 
the core mannose can be characterized similarly, using the same group of fragments with 
only a slight difference. As shown in Figure 5.6a, G1B also has two isomers. The 
terminal galactose positions can be assigned on the basis of the fragments 0,4A4α (m/z 
750.351) and C4α/Z3β (m/z 1125.542) in the spectrum of the first isomer (Figure 5.6b), and 
0,4A3β (m/z 546.252) and C3β/Z3α (m/z 921.441) in the spectrum of the second isomer 
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For example, the 0,4A4α fragment observed at m/z 750.351 in the spectrum presented in 
Figure 5.6b was assigned the same structure as the 0,4A4α′ fragment observed at m/z 
750.352 in the spectrum shown in Figure 5.5b, because they have the same composition 
in their 6′ arm. However, C4α/Z3β (m/z 1125.542) seen in Figure 5.6b is heavier than 
C4α′/Z3αʺ (m/z 880.416) seen in Figure 5.5b by a mass difference of 245.126 u, 
corresponding to the residue mass of an N-acetylglucosamine (HexNAc). Thus, a 
bisected structure with terminal galactose attached to the 6′ arm was assigned to the 
glycan which generated the spectrum shown in Figure 5.6b. The structure of glycoform in 
Figure 5.6c may be assigned in the same way. 
 
Figure 5.6 On-line nanoPGC-LC–EED-MS/MS analysis of deutero-reduced and permethylated 
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maximum of the elution peak of the first isomer. (c) EED spectrum acquired at the maximum of 
the elution peak of the second isomer. 
 
5.3.3 Determination of the linkages of terminal sialic acid residues in N-linked 
glycans 
Sialic acid is a very important oligosaccharide residue. Recent reports suggest that, not 
only the positions of sialic acid residues, but more importantly, their linkage types may 
influence the biological functions of sialylated glycans [261, 262]. Except in polysialic 
acid chains, terminal sialic acid is usually linked to either the C3 (α2→3) or C6 (α2→6) 
position of the penultimate galactose residue. The structures of glycoforms with a single 
sialic acid residue can be easily assigned on the basis of their EED spectra. PGC-LC 
analysis indicated that the G2S1 glycans whose EED spectra are shown in Figure 5.7a, 
consist of two isomers. The presence of 0,4A4β (m/z 750.352), 
3,5A4β (m/z 778.383) and 
C4β/Z3α (m/z 880.415) fragments in both spectra (Figure 5.7b and c) indicates that sialic 
acid is located at the terminus of the 3′ arm in both structures. The EED spectrum of the 
second and major isomer contains 0,4A2α (m/z 458.199) and C2α
•-OCH3 (m/z 588.263) 
fragments, which define the 2→6 linkage in this glycoform (Figure 5.7c). In the spectrum 
of the first and minor isomer, neither 0,4A2α nor C2α
•-OCH3 fragments are present. 
However, a very abundant singly charged fragment is observed at m/z 356.168 (Figure 
5.7b). It is labeled as C1α
•-C2H3O2. This fragment may be formed by the fragmentation 
pathway shown in Scheme 5.1a. Similar to other ions produced by EED, formation of this 








‡ = 2.5). We therefore propose that the sialic acid is 2→3 linked in the 
structure eluting as peak 1. In comparison, the abundance ratio of (C1α
•-C2H3O2/C2α
‡) in a 
reference glycan that contains 2→6-linked sialic acid is ~0.5 (Figure 5.7c). It seems 
possible that such an ion (C1α
•-C2H3O2) can also be generated when there is a 2→6 linked 
sialic acid via an alternative pathway, the most likely being initiation from a C4-C5 di-
radical of the neighboring galactose (Scheme 5.1b). Our previous theoretical calculation 
showed that formation of the C1-C2 di-radical is energetically favored over formation of 
the C4-C5 di-radical [238], resulting in a 5-fold difference in the abundance ratio of C1α
•-
C2H3O2/C2α
‡ for 2→6- and 2→6-linked sialic acid residues. After evaluating other sialic 
acid containing structures, including standards with defined linkages, we propose that this 
is a signature ratio that can allow differentiation among sialic acid linkages. The 
combination of information mentioned above provides definitive evidence that enables 





Figure 5.7 On-line nanoPGC-LC–EED-MS/MS analysis of deutero-reduced and permethylated 
N-glycans in human serum. (a) EIC of G2S1 in human serum. (b) EED spectrum acquired at the 
maximum of the elution peak of the first isomer. (c) EED spectrum acquired at the maximum of 































































































































































































































































































Scheme 5.1 Proposed EED mechanisms for the formation of C1•-C2H3O2 fragments in the EED 
spectra of glycans that contain (a) 2→3 and (b) 2→6 linked terminal sialic acid. 
 
Scheme 5.2 Sialic acid linkage-specific dimethyl-amidation, followed by reduction and 













subsequently produces a methyl ester upon permethylation. (b) sialic acid with a 2→6 linkage 
forms a dimethylated amide [112]. 
 
Although this approach works well for defining the linkage when a single sialic acid 
residue is present, it does not provide complete structural information for glycans with 
more than one sialic acid. For instance, PGC-LC MS analysis also revealed the presence 
of two G2S2 isomers were. (Figure 5.8a). The presence of the fragments 0,4A5 (m/z 
1111.527), 3,5A5 (m/z 1139.558) and C5/Z3 (m/z 1241.591) in EED spectra of both isomers 
indicates that a single sialic acid residue is attached to each arm. For linkage analysis, the 
presence of the fragments 0,4A2 (m/z 458.199), 
3,5A2 (m/z 486.231) and C2
•-OCH3 (m/z 
588.263) in both spectra (Figure 5.8b and c) specify that both glycoforms contain at least 
one 2→6-linked sialic acid. The abundance ratio of C1
•-C2H3O2 to C2
‡ in the EED 
spectrum of the second isomer is ~0.5, suggesting that both sialic acids were 2→6-linked 
(Figure 5.8c). For the first-eluting isomer, however, this ratio is close to 1. This ratio 
could correspond to the sum of contributions from one 2→3 linked and one 2→6 linked 
sialic acid residues (Figure 5.8b). However, it is not possible to specify which linkage is 





Figure 5.8 On-line nanoPGC-LC–EED-MS/MS analysis of deutero-reduced and permethylated 
N-glycans in human serum. (a) EIC of G2S2 in human serum. (b) EED spectrum acquired at 
maximum in the elution peak of the first isomer. (c) EED spectrum acquired at the maximum in 
the elution peak of elution of the second isomer. (d) EED spectrum of the first isomer after 













































































































































































































































































































































































































































































































































































































































































































































In order to solve this problem, the mixture of N-glycans released from the glycoproteins 
in human serum was derivatized via sialic acid linkage-specific amidation. The details of 
this derivatization reaction are shown in Scheme 5.2. The 2→3-linked sialic acid forms 
an intramolecular lactone, that is subsequently reopened and blocked during reduction 
and permethylation (Scheme 5.2a), whereas the 2→6-linked sialic acid forms an amide 
with the dimethylamine, which is retained during the following by reduction and 
permethylation steps (Scheme 5.2b). Though, the modified sample preparation protocol 
does not ultimately affect product obtained from permethylation of 2→3-linked sialic 
acid, the process does lead to a mass increase of 13.031 u on each 2→6-linked sialic acid, 
and this mass shift greatly facilitates accurate glycoform assignment. The two isomers of 
G2S2 discussed above were re-analyzed by PGC-LC–EED-MS/MS after the released 
glycans were derivatized using the modified sample preparation protocol. As a result, the 
precursor mass increased by 13.031 u in the EED spectrum of the first-eluting isomer 
(m/z shift of 4.344 Th for the 3+ ion) and a shift corresponding to 26.063 u in the 
spectrum of the second isomer (m/z shift of 8.688 Th for the 3+ ion), respectively, which 
confirms our initial assignment. In order to assign correct sialic acid linkages to the two 
arms in the structure of the first isomer (Figure 5.8d), the m/z values of linkage-specific 
0,4A, 3,5A and C/Z ions, before and after amidation, were compared. The fragments that 
can be assigned as 0,4A5α (m/z 1124.558), 
3,5A5α (m/z 1152.589) and C5/Z3β (m/z 1254.621) 
in Figure 5.8d are each 13.031 u heavier than the corresponding peaks in the glycans that 
had not been subjected to amidation: 0,4A5 (m/z 1111.527), 




(m/z 1241.591) in Figure 5.8b. This result made it possible to assign the 2→6-linked 
sialic acid to the 6′ arm, leaving 2→3-linked sialic acid on the 3′ arm. 
 
5.3.4 Determination of the position of fucosylation in N-linked glycans 
Fucosylation has significant implications in cancer and inflammation [263]. The 
occurrence and position of fucosylation are controlled by the activity of specific fucosyl-
transferases. Recent glycomics research revealed that the levels of fucosylation observed 
on some secretory or membrane glycoproteins are closely related to certain types of 
cancers, and may even be utilized as glyco-biomarkers. For instance, elevated levels of 
fucosylation on alpha-fetoprotein or haptoglobin have been observed in various 
hepatocellular carcinomas [264]. When the detailed structures and locations of the 
modified glycans have been determined, the fucosylation patterns have been found to be 
site-specific [265]. 
 
Fucosylation occurs most frequently at the inner HexNAc of the trimannosyl chitobiose 
core of N-linked glycans, but fucose can also be attached to branches of the antennae. As 
shown in Figure 5.9a, PGC-LC analysis revealed the presence of at least three G2S1F 
isomers. Their detailed structures, especially regarding the position of fucosylation, can 
be assigned on the basis of their respective EED spectra acquired on-line. Among them, 
the EED spectra of the second (Figure 5.9c) and third (Figure 5.9d) eluting isomers 
indicate core fucosylation for both isomers, on the basis of the observed Z1 (m/z 473.258), 




fucose on the first eluting isomer (Figure 5.9b) could be assigned to an antenna, on the 
basis of its Z1 (m/z 299.168), Y1 (m/z 317.179), Z2 (m/z 544.295), and Y2 (m/z 562.306) 
fragments. Finally, application of the fragmentation rules defined in Figure 5.1 specified 
the location of the fucose to the C3 position of the HexNAc residue on the 6′ arm, based 
on the presence of the C4β/Z3α (m/z 1054.503), 




Figure 5.9 On-line nanoPGC-LC–EED-MS/MS analysis of deutero-reduced and permethylated 
N-glycans in human serum. (a) EIC of G2S1F in human serum. (b) EED spectrum acquired at the 






32 34 36 38 40 42 44 46 48 R.T. [min]
EIC (m/z 889.4424)(a)













































































































































































































































































































































































































































































































the elution peak of the second isomer. (d) EED spectrum acquired at the maximum in the elution 
peak of the third isomer. 
 
Fucosylation on more complicated glycoforms can also be identified precisely by our 
EED-based MS/MS method. After fractionation & enrichment, some very low-abundance 
glycoforms of G3S3 and G3S3F were characterized. As shown in Figure 5.10, the most 
abundant isomer of G3S3F (Figure 5.10c) shares a similar structure with the most 
abundant isomer of G3S3 (Figure 5.10b) except for the addition of a fucose residue. 
Thereupon, G3S3F can be viewed as the fucosylated form of G3S3. In this case, it was 
straightforward to determine that the fucose residue is not located on the core HexNAc, 
since the two spectra exhibit the same Z1 (m/z 299.169), Y1 (m/z 317.179), Z2 (544.295), 
and Y2 (m/z 562.306) fragments. Fucosylation on the 6′ arm was eliminated as a 
possibility, since the residue composition on the 6′ arm was determined to be 
HexNAc(1)Hex(2)NeuAc(1) through observation of the same 0,4A5β (m/z 1111.525), 
3,5A5β (m/z 1139.557) and C5β/Z3α (m/z 1241.588) fragments in the spectra of both 
structures, and therefore the location of fucosylation was limited to the 3′ arm. In this 
candidate structure, the 3′ arm divides into two sub-branches. Localization of the 
fucosylation site within the 3′ arm may be assisted by the diagnostic C/Y ion. As 
discussed earlier (Figure 5.1e), the presence of a C/Y fragment is diagnostic for 1→2 
linkage. Based on the shift of C4α/Y4α (m/z 1055.499) in G3S3 to C4α’/Y4αʺ (m/z 1229.588) 




the fucosylation site of the G3S3F glycoform could be determined, as shown in Figure 
5.10c. 
 
Figure 5.10 On-line nanoPGC-LC–EED-MS/MS analysis of enriched deutero-reduced and 
permethylated N-glycans in human serum. (a) EIC of G3S3F in human serum. (b) EED spectrum 
of G3S3. (c) EED spectrum acquired at the maximum in the elution peak of the G3S3F isomer. 
 
5.3.5 Fractionation & enrichment of low-abundance glycoforms 
N-linked glycosylation in human serum is extremely complicated. In this study, more 
than 50 glycoforms were detected, among which, more than half have relatively low 
abundances. This makes it very difficult to get high quality EED spectra during a single-
stage LC–MS/MS analysis. Considering the limited binding capacity of the nanoLC 
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and interference from abundant species, it became necessary to carry out off-line 
fractionation of the whole pool of released N-glycans by RPLC for selective enrichment 
of certain fractions prior to on-line nanoPGC-LC–EED-MS/MS analysis of low-
abundance glycoforms. This led to a more than two-fold increase in the number of 
characterized glycoforms. As shown in Figure 5.2, detailed structures of 54 N-glycans 
were determined. Among them, 21 structures were identified in single-stage nanoPGC-
LC–EED-MS/MS analysis, and the remaining 33 glycoforms were characterized by re-
analysis after off-line fractionation and enrichment. The lower abundance fractions were 
found to be populated by many bisected and multiply sialylated structures. This result 
demonstrated the importance and necessity of fractionation and enrichment for achieving 
deep analysis of complex mixtures of glycans containing components with significantly 
varied concentrations. 
 
5.3.6 PGC-LC–MS/MS analysis of O-linked oligosaccharides 
To test its potential for analyzing other classes of glycans, the developed PGC-LC–EED-
MS/MS method was also applied to analysis of O-linked glycans. Compared to the mass 
spectrometric analysis of N-linked glycans, the analysis of O-linked glycans is more 
challenging, largely because the structures of O-linked glycans are more varied. The O-
GalNAc glycans have eight core structures in total (Figure 1.10), among which, cores 1 
to 4 are considered the major core structures, since they are more commonly detected 
than cores 5 to 8. Each core can be extended via addition of different glycan residues to 




described for the EED analyses described above, a total of 58 O-glycoforms were 
characterized in bovine submaxillary mucin (an example is given in Figure 5.12). Among 
them, 34 glycoforms were characterized in single-stage nanoPGC-LC–MS/MS analysis, 
and the remaining 24 structures were identified by further analysis performed after off-
line fractionation & enrichment. 
 
Figure 5.11 O-linked glycans identified in bovine submaxillary mucin. Glycoforms in the red 






Figure 5.12 On-line nanoPGC-LC–EED-MS/MS analysis of enriched deutero-reduced and 
permethylated O-glycans in bovine submaxillary mucin. (a) EIC of HexNAc(3)Hex(1)Fuc(1) in 
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the first isomer. (c) EED spectrum acquired at the maximum of the elution peak of the second 
isomer. (d) EED spectrum acquired at the maximum of the elution peak of the third isomer. (e) 
EED spectrum acquired at the maximum of the elution peak of the fourth isomer. (f) EED 
spectrum acquired at the maximum of the elution peak of the fifth isomer. 
 
5.4 Conclusions 
In this study, the capability of PGC-LC–EED-MS/MS for structural analysis of complex 
mixtures of glycans was explored. Benefiting from the superb separation performance of 
PGC-LC and the exceptional fragmentation efficiency of EED, detailed structural 
characterizations of 54 N-linked glycans in human serum and 58 O-linked glycans in 
bovine submaxillary mucin were accomplished. Analyses of low-abundance species were 
facilitated by off-line fractionation and enrichment, which proved to be an essential step 
for analyzing complex mixtures with components whose concentrations span a wide 
dynamic range. Sialic acid linkage-specific amidation was successfully incorporated in 
the sample preparation workflow for accurate linkage assignment on terminal sialic acid 
residues. PGC-LC–EED-MS/MS was demonstrated to be a powerful approach for facile 
and comprehensive glycome characterization. 
 
In the future, our methods for de novo structural analysis could be applied to different 
types of glycans derived from a variety of biological sources, including not only N-linked 
and O-linked glycans, but also milk oligosaccharides and bacterial glycoconjugates that 
are often composed of novel monosaccharides and lack the trimannosyl chitobiose core in 










Chapter 6: Conclusions and future perspectives 
6.1 Conclusions 
As a powerful element in the glycomics toolkit, MS is extensively used for qualitative 
and quantitative analysis of various types of glycans. The research summarized in this 
dissertation has accomplished the objectives of developing advanced FT-ICR MS-based 
methods for glycan analysis and applying them to comprehensive glycan structural 
characterization. The accomplishments were dependent on the complementary properties 
and progress made in the execution of three crucial techniques: porous graphitized carbon 
liquid chromatography (PGC-LC), gated-trapped ion mobility spectrometry (Gated-
TIMS), and electronic excitation dissociation (EED). Each of these key components was 
extensively explored and specifically optimized in order to achieve effective isomer 
separation and efficient glycan fragmentation. 
 
This dissertation begins with understanding, optimizing and applying EED for glycan 
structural analysis and isomer differentiation. In Chapter 2, EED spectra acquired from 
various glycan standards showed excellent potential for identifying isomeric structures. It 
was established that EED could generate extensive fragmentations that provide detailed 
sequence and linkage information. For glycan topology (sequence) analysis, EED spectra 
were characterized by prominent Z-, Y-, and 1,5X-ion series. For linkage determination, 
linkage diagnostic cross-ring and secondary fragments were recognized.  Pathways were 
proposed for formation of all the diagnostic fragments from the di-radical intermediate 




patterns elucidated here are valuable for de novo sequencing of unknown glycan 
structures. 
 
The analytical potential of coupling Gated-TIMS separation with EED for 
characterization of isomeric glycan mixtures was explored in Chapter 3. Because of the 
high mobility resolving power of Gated-TIMS, glycan isomers could be well separated, 
and their detailed structures were characterized by online EED analysis. In addition, it 
was shown that Gated-TIMS can also function in negative mode with uncompromised 
performance, as demonstrated by Gated-TIMS–NETD-MS/MS analysis of 
glycosaminoglycan isomers. 
 
Further research described in this dissertation investigated the capability of LC–EED-
MS/MS for analysis of isomeric glycan mixtures. In Chapter 4, EED was coupled with 
RPLC, and the EED behavior of glycans that were permethylated to increase their 
interactions with the hydrophobic stationary phase was also determined. EED tandem 
mass spectra acquired online contained many structurally informative fragments; the 
translation of those fragments into correct structures required development of a sound 
understanding of the EED fragmentation process. The results showed great promise for 
resolving and characterizing complex glycan isomers in a single RPLC–EED-MS/MS 
run. RPLC–EED-MS/MS represents an important step towards the development of a LC 
and EED-based approach for comprehensive glycome characterization. To further 




fragments from co-eluting isomers, PGC-LC was employed to replace RPLC as PGC-LC 
is one of the best chromatographic methods for resolving isomeric glycans. In Chapter 5, 
PGC-LC–EED-MS/MS was applied for comprehensive and systematic characterization 
of N-linked and O-linked glycans from biological sources. To increase the information 
content of the spectra and the dynamic range, two additional strategies were ultimately 
included: sialic acid linkage-specific amidation to achieve accurate sialic acid linkage 
assignments and off-line fractionation and enrichment by RPLC to facilitate analysis of 
low-abundance glycoforms. 
 
Another important progress throughout this dissertation is the development of an 
automated MS/MS spectra interpretation algorithm, GlycoDeNovo, in a collaborative 
project. EED spectra generated over the course of the projects described herein 
contributed essential data for the development of the IonClassifier underlying the 
topology ranking algorithm. In Chapters 2 and 5, glycan topologies were determined via 
deconvoluting their complex EED spectra by GlycoDeNovo with unbiased reconstruction 
and intelligent ranking. 
 
In conclusion, this dissertation presents my recent efforts toward developing and applying 
FT-ICR MS-based analytical methods for the separation and detailed structural analysis 
of glycans. PGC-LC–EED-MS/MS and Gated-TIMS–EED-MS/MS are now established 





6.2 Future perspectives 
The PGC-LC–EED-MS/MS platform developed in this dissertation shows great promise 
to bring about a revolutionary change in the pursuit of comprehensive glycomics. Future 
advancement will focus on improving sensitivity, increasing throughput, and automating 
spectra interpretation. 
 
Currently, on-line EED is carried out on a Bruker solariX FT-ICR mass spectrometer, 
where each EED scan takes about 2.8 sec (2 sec accumulation + 0.5 sec irradiation + 0.3 
sec detection). In addition, signal averaging of multiple scans is usually necessary to 
obtain high-quality EED spectra. Therefore, it takes a relatively long time for on-line 
EED analysis of each precursor ion, and this limits the throughput when analyzing 
complex glycan mixtures. Faster MS analyses and more efficient EED implementations, 
such as IM-ExD-QTOF MS and QE-OrbitrapMS with ExD in an Omnitrap, are now 
being explored in Boston University Center for Biomedical Mass Spectrometry and 
collaborating laboratories. The fundamental and mechanistic studies reported here should 
provide a firm platform to support these further investigations.  
 
For high-throughput glycan structural characterization, it is crucial to have intelligent 
bioinformatics algorithms that are able to perform spectral deconvolution and structural 
reconstruction automatically. To date, GlycoDeNovo already exhibited great potential for 




with a larger structural diversity could provide extensive training datasets to optimize 
topology analysis and facilitate automated linkage analysis. 
 
Another potential application of PGC-LC–EED-MS/MS is the analysis of other types of 
molecules. PGC-LC–EED-MS/MS is a central development of this dissertation because 
of its potential for analyzing isomeric glycans. It has been extensively optimized for 
separation and fragmentation of glycans. One suggested application is its use for 
metabolite profiling, since isomeric structures are also commonly encountered in 
metabolomics. In some cases, PGC should be able to separate isomeric metabolites that 
cannot be resolved by other LC methods, e.g., citrate and isocitrate in the tricarboxylic 
acid cycle, or 2-phosphoglycerate and 3-phosphoglycerate in the glycolysis pathway. 
 
In conclusion, MS is emerging as a remarkable and essential technology to support 
glycomics studies. The work reported here demonstrates that new capabilities can be 
realized through patient and thorough investigation, careful data interpretation, 
optimization of methods, and the combination of promising approaches. It is expected 
that even more powerful MS-related analytical techniques will be created in the near 
future to enable high-throughput determination of glycan structures, thereby facilitating 
the exploration of their structure-function relationships. This author will be very pleased 
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